rfhg_203262.1

Basic information about the TSS

---

TSS ID: rfhg_203262.1 Species: human Chr: chr18		Start: 49813928 End: 49813965 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3007488,EH38E1916109)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000587994.5:0 ENST00000586485.5:0 ENST00000586100.1:0 GeneID: 10449 HGNC/MGI_ID: HGNC:83 UniProt_ID: A0A0B4J2A4 K7EJ68 K7ER88 Nearer transcript ids and distances: AK314462:46 AK054673:47 ENST00000285093.15:395 NM_006111.3:395 AK225457:396 D16294:396 BC001918:425 AB529169:440 DQ893376:442 DQ896697:442 KJ893045:443 CU674934:443 view more...

Gene_name: acetyl-CoA acyltransferase 2 Gene_symbol: ACAA2 Gene_synonyms: DSAEC Gene_source: HGNC:83

TATA-Box annotation

---

Distance to TSS:	-77
Nearest PromoterID:	NR_003003
Entrez ID:	677769
Nearest Unigene:
Nearest Refseq:	NR_003003
Nearest Ensembl:	ENSG00000267322
Gene Name:	acetyl-CoA acyltransferase 2
Gene Alias:	U91
Gene Type:	ncRNA
CpG%:	0.135135
GC%:	0.789474
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ACAA2 p2@ACAA2 p3@ACAA2 p4@ACAA2 p5@ACAA2 p6@ACAA2 p7@ACAA2 p8@ACAA2 p9@ACAA2
Sample		p1@ACAA2	p2@ACAA2	p3@ACAA2	p4@ACAA2	p5@ACAA2	p6@ACAA2	p7@ACAA2	p8@ACAA2	p9@ACAA2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	8.96	3.70	8.77	1.17	0.97	0.78	0.58	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	8.90	2.63	9.10	2.43	1.01	0.61	0.40	0.20	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	12.54	3.86	9.84	2.12	1.54	0.77	0.77	0.19	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	12.27	4.16	7.90	0.62	1.66	0.83	1.04	0.00	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	10.57	3.60	10.12	2.02	0.90	1.12	0.22	0.22	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	10.85	4.46	7.56	1.74	0.58	0.78	0.00	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	20.48	5.66	11.33	1.09	0.65	0.87	0.00	0.22	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	11.38	6.54	9.20	0.97	0.97	2.18	0.97	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	13.89	5.34	5.34	0.85	1.07	1.28	0.21	0.00	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	16.23	3.48	12.17	1.74	1.16	3.48	1.74	0.00	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	13.34	4.04	9.70	1.62	2.43	0.81	0.00	0.00	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	15.86	1.22	13.01	1.22	1.63	1.63	0.81	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	19.02	14.83	2.90	0.81	1.93	1.77	0.00	0.81	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	21.35	15.79	2.71	0.75	0.75	1.35	0.45	0.15	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	19.54	11.42	2.42	0.22	1.32	1.76	0.00	0.88	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	22.89	17.60	3.77	0.50	0.50	2.01	0.50	1.51	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	21.19	17.04	1.09	0.66	1.31	2.40	0.22	0.66	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	23.20	16.03	2.11	0.42	1.27	0.84	0.00	1.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	22.39	17.59	1.60	0.53	0.00	3.73	0.00	1.07	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	20.76	15.35	2.11	0.90	0.75	3.46	0.30	0.60	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	24.06	14.30	3.21	1.20	0.94	3.07	0.27	0.40	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	29.17	18.13	2.93	1.38	0.69	1.55	0.35	0.52	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	23.27	15.51	2.71	0.65	0.78	1.16	0.26	1.16	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	27.18	17.47	4.61	2.43	1.94	1.70	0.00	1.21	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	24.25	17.29	2.84	1.03	1.55	2.58	0.00	0.26	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	21.21	16.46	4.11	0.00	0.95	3.17	0.32	0.95	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	28.57	21.98	3.85	0.00	0.00	1.10	0.00	1.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	23.58	15.32	3.77	1.89	0.71	1.65	0.24	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	22.45	11.15	2.75	0.97	1.13	2.42	0.16	0.81	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	23.71	18.46	2.90	1.09	1.99	0.90	0.18	1.09	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	27.42	13.19	2.09	0.84	0.63	1.88	0.21	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	22.08	12.70	2.93	0.39	0.39	1.76	0.20	0.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	23.00	14.14	1.48	0.84	0.42	1.48	0.42	0.84	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	41.56	15.50	2.80	0.99	0.33	2.31	0.16	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	23.19	13.46	2.24	1.12	1.50	1.12	0.56	1.50	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	20.12	14.56	3.07	0.77	1.15	2.49	0.00	0.96	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	20.64	13.90	2.25	0.61	1.64	2.04	0.61	1.43	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	17.93	14.31	3.43	1.01	1.41	1.41	0.81	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	21.34	16.21	2.43	0.81	0.27	3.78	0.27	1.89	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	21.37	14.88	3.36	1.44	1.20	2.40	0.00	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	23.53	9.41	2.82	0.00	3.06	1.41	0.47	1.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	27.96	16.54	2.93	1.32	0.88	3.22	0.00	0.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	19.40	12.44	3.37	1.69	0.84	2.74	0.21	0.42	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	18.01	12.24	2.80	1.05	0.70	3.32	0.52	0.87	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	19.47	12.05	2.81	0.80	0.80	2.41	0.20	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	21.40	10.00	2.33	1.40	1.40	2.56	0.23	0.93	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	18.47	15.59	2.64	0.24	1.44	2.64	0.48	0.72	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	20.86	13.11	2.09	0.30	1.19	1.79	0.30	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	20.35	14.36	2.15	0.24	0.72	2.63	0.48	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	19.61	11.32	2.22	1.21	1.01	3.24	0.20	0.81	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	17.63	11.68	1.64	0.41	0.41	1.84	0.20	0.41	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	14.90	8.23	1.78	0.89	0.44	2.45	0.22	0.67	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	111.94	41.98	0.00	0.00	0.00	27.98	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	12.42	18.10	1.77	0.00	1.42	1.42	0.00	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	12.92	11.27	0.33	0.33	1.99	0.33	0.33	1.66	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	45.30	20.13	10.07	0.00	0.00	5.03	0.84	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	25.26	12.40	2.30	0.46	0.00	4.13	0.00	0.92	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	10.37	8.10	1.30	0.97	0.65	1.62	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	12.20	7.07	0.96	0.64	1.93	3.53	0.32	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	25.46	14.77	5.34	0.63	0.94	4.09	0.31	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	9.87	9.87	0.71	0.00	2.12	1.41	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	14.58	7.29	0.00	0.56	1.12	1.68	1.12	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	20.70	11.15	5.57	0.00	0.00	3.98	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	13.25	12.23	1.36	0.34	0.34	2.72	0.34	0.68	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	11.05	8.45	0.65	0.65	0.65	1.62	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	4.26	3.55	1.42	0.00	2.13	1.77	0.35	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	32.33	32.33	0.00	0.00	48.49	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	31.59	63.18	15.79	0.00	0.00	23.69	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	3.90	8.78	0.49	0.00	2.44	0.98	0.98	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	3.47	10.41	1.98	0.00	1.49	0.50	0.50	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	3.75	7.04	0.94	0.47	1.41	1.41	0.47	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	6.62	3.64	2.98	0.33	1.66	1.99	0.33	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	3.09	8.04	0.62	0.93	1.24	1.24	0.31	0.31	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	6.73	8.87	0.31	0.92	1.22	1.22	0.61	0.92	0.00
Adipocyte - breast, donor1	11376-118A8	48.15	17.26	2.38	1.11	2.38	2.69	0.16	0.32	0.16
Adipocyte - breast, donor2	11327-117E4	167.00	18.61	1.93	0.80	0.96	2.41	0.64	0.48	0.16
Adipocyte - omental, donor1	11473-119C6	122.52	17.05	2.67	1.78	1.91	3.56	0.25	0.64	0.13
Adipocyte - omental, donor2	11474-119C7	59.80	17.19	1.49	2.24	0.75	4.48	2.24	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	96.46	13.06	4.69	2.34	3.01	3.35	0.67	1.34	0.00
Adipocyte - perirenal, donor1	11476-119C9	20.42	15.31	1.91	1.28	1.91	0.64	0.00	0.00	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	126.44	12.09	1.10	0.00	2.20	1.10	2.20	0.00	2.20
Adipocyte - subcutaneous, donor2	11336-117F4	98.45	17.61	0.90	0.00	2.26	2.71	0.90	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	224.00	29.54	1.74	0.52	8.34	3.48	1.04	0.87	1.22
Adipocyte differentiation, day04, donor1	13019-139D4	124.97	27.97	2.15	1.76	5.67	3.32	1.56	0.59	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	50.70	15.44	1.54	0.51	2.57	0.77	2.57	1.03	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	68.58	25.65	2.23	0.84	3.35	2.51	2.79	0.84	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	94.05	24.69	5.29	0.00	1.76	3.53	1.18	1.76	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	787.60	46.73	5.55	1.05	1.61	6.11	1.05	1.45	0.64
Adipocyte differentiation, day08, donor2	13023-139D8	187.20	21.30	1.61	0.65	4.84	2.58	2.90	0.65	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	214.34	23.46	3.20	1.60	5.33	3.73	0.53	1.07	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	308.27	26.15	2.78	0.56	4.45	2.23	1.11	2.23	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	672.91	48.24	4.57	0.00	4.57	2.91	3.33	1.66	2.08
Adipocyte differentiation, day12, donor2	13024-139D9	270.51	21.85	2.51	1.00	2.51	2.26	2.26	0.50	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	371.75	32.72	1.64	0.98	1.96	4.58	1.64	0.98	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	459.14	30.75	2.74	1.52	3.04	3.96	0.30	0.61	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	21.22	9.72	2.21	1.10	0.88	1.10	0.22	0.22	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	10.40	2.87	2.15	0.36	1.43	0.36	2.15	0.00	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	3.59	3.59	1.20	0.00	0.00	1.20	0.00	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	5.40	9.00	5.04	1.62	0.36	0.54	0.18	0.18	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	1.67	10.04	0.00	0.00	0.00	5.02	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	3.70	4.73	3.70	1.44	0.82	0.62	0.41	0.41	0.21
Anulus Pulposus Cell, donor1	11248-116E6	61.45	35.13	5.72	3.66	0.46	2.52	0.23	1.37	0.00
Anulus Pulposus Cell, donor2	11463-119B5	26.45	17.88	2.69	2.45	0.49	0.98	0.24	0.73	0.98
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	26.96	9.44	4.04	0.00	0.45	1.35	0.00	0.90	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	32.99	16.06	1.30	1.30	1.30	2.17	0.43	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	27.82	8.56	0.00	4.28	4.28	0.00	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	35.57	12.85	3.89	0.90	0.90	2.39	1.49	0.30	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	41.73	12.65	3.79	2.53	2.53	5.06	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	19.80	8.58	3.30	1.98	3.30	0.66	2.64	0.66	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	33.46	10.40	2.92	0.00	0.32	1.30	0.65	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	30.10	12.14	3.40	1.46	1.46	6.80	1.46	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	29.10	11.88	2.97	0.59	2.97	2.97	1.78	1.78	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	31.64	16.57	3.39	0.75	1.51	1.13	0.38	1.51	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	26.12	13.06	2.18	1.45	0.00	2.18	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	31.34	12.54	1.25	1.25	8.78	2.51	2.51	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	47.61	15.49	5.77	1.48	2.47	3.46	0.49	1.32	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	30.03	9.55	6.82	0.00	1.36	2.73	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	30.76	17.94	2.56	1.36	7.69	3.17	2.87	0.30	0.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	31.61	9.64	4.29	0.00	0.00	1.61	1.07	0.00	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	27.77	12.28	3.78	1.32	3.02	2.08	1.70	0.19	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	28.87	11.76	2.14	1.07	1.60	2.41	1.60	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	25.36	4.88	0.98	0.98	1.95	1.95	0.00	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	26.37	11.61	3.81	1.33	1.82	3.15	1.33	1.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	32.42	8.41	6.00	0.00	8.41	1.20	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	31.86	7.08	3.54	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	26.07	10.98	3.60	1.03	2.40	2.57	1.03	0.51	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	25.17	4.19	0.00	0.00	0.00	0.00	0.00	0.00	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	36.89	16.02	2.43	0.97	0.49	3.40	0.00	1.46	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	36.05	17.08	2.66	0.76	3.04	2.66	1.14	0.76	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	29.07	9.69	6.06	0.00	3.63	0.00	3.63	2.42	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	42.18	12.54	5.70	2.28	1.71	1.71	0.57	0.57	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	28.65	13.47	2.78	0.43	0.64	2.78	1.28	0.64	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	26.33	10.07	1.55	1.03	3.61	2.58	1.55	0.00	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	31.91	11.26	0.47	0.00	0.00	3.28	0.94	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	23.15	11.25	2.89	0.64	2.25	3.22	1.29	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	29.96	10.70	0.71	0.71	2.85	1.43	4.99	0.71	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	22.23	13.45	2.34	2.34	1.75	1.75	1.17	0.00	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	26.80	14.15	3.91	0.90	2.71	0.90	1.51	0.60	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	23.76	23.76	2.38	1.19	5.94	2.38	2.38	0.00	2.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	35.09	12.71	0.51	2.03	0.00	1.53	2.03	0.00	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	29.29	14.52	3.31	1.27	3.06	3.06	2.29	0.25	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	29.86	8.90	0.00	1.27	5.08	3.18	2.54	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	29.78	13.81	1.73	0.86	2.16	2.59	0.00	0.86	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	23.92	12.49	4.23	0.64	2.33	1.27	1.69	0.21	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	22.91	13.34	3.19	0.58	3.48	2.61	3.48	0.29	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	28.34	10.39	2.83	1.89	0.00	4.72	0.94	2.83	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	22.89	10.17	3.73	1.19	2.20	2.88	1.19	0.51	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	27.80	2.32	2.32	0.00	6.95	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	40.14	8.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	25.30	12.22	2.57	1.29	1.93	2.57	1.50	1.07	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	24.67	15.64	1.80	2.41	1.80	2.41	1.80	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	30.62	13.85	5.10	0.73	2.19	3.64	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	26.67	11.03	1.15	2.07	2.53	2.53	1.15	0.00	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	22.95	2.55	2.55	5.10	10.20	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	41.69	16.78	2.29	0.51	7.88	2.03	2.80	1.02	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	22.50	11.77	3.10	1.03	1.24	3.30	1.03	0.41	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	15.91	12.55	2.14	0.61	1.84	3.67	1.53	0.00	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	32.98	12.91	4.78	0.00	1.43	1.91	1.43	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	23.28	11.53	2.44	0.22	1.33	2.44	1.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	22.89	9.15	1.53	0.00	4.58	3.05	4.58	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	22.71	9.42	3.88	0.55	1.11	2.77	0.55	0.00	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	17.48	9.53	2.65	0.79	1.85	1.32	1.06	0.00	1.32
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	24.35	10.90	3.27	0.36	5.45	1.82	2.18	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	9.33	7.37	5.65	1.84	0.37	2.09	0.00	0.49	0.00
Astrocyte - cerebellum, donor2	11580-120F5	5.65	5.99	2.74	2.91	0.34	1.20	0.17	0.51	0.17
Astrocyte - cerebellum, donor3	11661-122F5	4.82	6.29	3.15	1.47	0.84	2.52	1.05	0.63	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	51.24	23.36	10.81	10.81	2.79	2.44	1.39	1.05	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	27.18	18.28	9.54	3.56	1.29	2.91	1.94	0.32	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	24.46	17.60	8.80	4.62	1.79	1.64	1.64	1.79	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	41.86	34.06	12.73	6.31	0.00	0.80	0.23	1.72	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	38.34	29.82	12.78	5.01	0.13	0.38	0.50	2.13	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	38.35	31.75	13.31	4.55	0.11	0.80	0.34	1.14	0.00
Basophils, donor1	12241-129G9	10.46	8.11	1.31	0.78	6.54	1.57	2.62	0.00	0.26
Basophils, donor2	12242-129H1	40.77	19.84	2.53	0.36	23.81	1.44	7.94	0.72	2.89
Basophils, donor3	12243-129H2	12.49	9.26	2.06	0.29	3.82	1.32	2.06	0.73	0.73
Bronchial Epithelial Cell, donor1	11511-119G8	12.94	5.82	1.29	0.00	1.08	1.08	0.65	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	0.91	0.91	0.46	0.46	1.83	0.00	1.83	0.00	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	7.17	0.00	0.00	0.00	0.00	0.00	0.00	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	6.28	1.88	0.00	0.00	1.88	0.63	0.63	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	1.25	1.66	0.00	0.42	0.62	0.00	0.42	0.42	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	1.61	3.45	0.46	0.23	0.46	0.23	0.46	0.46	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	7.20	7.20	0.90	0.72	0.18	0.18	0.72	0.00	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	12.26	14.32	11.03	3.50	0.21	0.21	0.21	0.52	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	26.55	16.54	11.41	5.59	2.56	0.47	1.63	2.10	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	27.18	29.42	9.91	1.60	12.15	1.60	0.96	1.28	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	10.34	10.34	10.34	20.68	0.00	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	12.96	15.22	1.69	0.00	3.94	1.13	3.38	1.13	1.69
CD14+ Monocytes, donor2	11305-117B9	7.61	6.12	1.48	0.74	0.93	0.93	1.48	0.56	0.74
CD14+ Monocytes, donor3	11381-118B4	12.73	5.71	2.41	0.66	12.29	1.10	7.68	0.00	1.98
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	38.49	31.98	11.32	2.83	1.13	3.11	1.98	1.70	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	36.77	34.50	12.89	0.76	3.79	4.55	1.52	1.52	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	31.23	33.53	8.88	1.64	0.66	1.97	0.33	1.97	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	17.49	16.48	2.60	0.00	2.17	1.88	1.01	0.14	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	13.58	8.15	0.60	0.30	1.51	1.51	0.30	0.30	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	17.77	11.61	2.61	0.24	0.95	2.37	0.24	0.24	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	16.40	11.89	2.34	0.33	1.84	2.18	0.33	0.17	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	12.42	5.24	1.38	0.55	2.48	2.48	0.55	0.00	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	16.36	6.20	0.25	0.00	1.24	1.74	0.00	0.00	0.50
CD14+ monocytes - treated with BCG, donor1	11860-125A6	21.15	14.88	1.96	0.20	2.15	0.78	1.37	0.39	0.78
CD14+ monocytes - treated with BCG, donor2	11870-125B7	10.86	5.34	1.42	0.00	2.31	1.42	0.71	0.18	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	27.42	11.53	1.96	0.00	4.13	2.39	0.22	0.44	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	14.98	10.77	0.94	0.23	1.17	3.04	0.47	0.00	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	11.62	4.75	1.58	0.00	1.06	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	12.20	12.20	0.00	0.00	1.11	2.22	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	28.71	15.32	2.53	0.30	2.23	3.12	0.45	0.15	0.59
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	26.94	12.77	1.40	0.20	1.00	3.19	0.00	0.40	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	42.26	22.28	3.12	0.00	0.21	3.12	0.00	0.62	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	26.31	13.96	2.29	0.00	2.29	3.89	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	18.10	9.27	0.90	0.00	1.81	1.36	0.00	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	19.64	8.29	3.06	0.00	3.93	3.06	0.44	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	14.26	10.49	1.88	0.00	1.34	1.61	0.81	0.00	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	14.65	11.17	2.09	0.35	1.74	2.62	0.00	0.17	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	15.57	13.05	2.10	0.00	2.10	3.37	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	15.98	10.29	0.73	0.55	2.20	2.94	0.92	0.37	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	12.68	6.69	1.06	0.00	1.76	2.11	0.35	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	12.28	7.90	1.32	0.00	2.19	3.95	0.44	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	15.17	10.81	2.79	0.52	3.31	1.74	1.22	0.35	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	12.27	7.06	3.35	0.37	1.49	1.49	1.12	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	27.37	13.80	3.23	0.22	1.51	1.29	0.22	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	14.33	7.37	2.87	0.41	2.05	0.41	2.05	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	13.21	5.56	0.23	0.00	1.85	0.70	0.46	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	17.17	7.42	2.55	0.00	2.09	1.62	0.23	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	22.89	23.76	1.74	0.44	0.44	1.96	0.22	1.53	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	33.26	34.42	2.77	0.46	1.15	1.15	0.23	1.15	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	25.99	23.39	3.68	0.22	1.52	1.95	0.22	0.87	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	16.97	19.93	4.05	1.40	1.56	1.87	0.16	0.93	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	28.12	28.12	2.27	0.52	1.22	1.92	0.00	1.57	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	14.49	21.63	5.13	0.45	0.67	2.45	0.00	0.45	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	17.10	23.22	4.08	0.26	1.02	3.32	0.77	1.79	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	30.52	26.79	6.15	0.44	2.20	4.39	0.66	0.22	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	23.16	23.79	6.95	0.84	2.53	3.37	0.42	1.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	12.19	14.23	4.06	4.06	4.06	0.00	0.00	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	18.98	17.63	2.71	4.07	7.46	0.00	2.03	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	13.46	18.64	0.00	2.07	2.07	1.04	4.14	0.00	2.07
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	13.86	15.99	8.00	2.13	6.93	1.60	1.60	1.60	1.60
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	26.27	17.69	4.29	2.68	6.43	0.00	1.61	1.61	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	28.78	21.06	4.91	2.81	5.62	0.00	0.70	1.40	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	12.55	17.26	7.84	3.14	5.49	0.00	3.14	0.78	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	22.41	32.96	6.59	3.95	2.64	0.00	2.64	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	2.47	8.22	2.47	0.82	1.64	0.00	4.11	0.82	2.47
CD19+ B Cells, donor2	11624-122B4	3.63	6.53	1.45	0.73	2.18	0.73	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	3.03	5.05	2.52	0.50	1.01	0.00	2.52	1.01	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	92.13	32.73	5.25	0.40	5.25	6.06	1.62	1.21	3.64
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	70.31	26.77	5.19	0.80	15.58	4.79	3.99	0.00	2.00
CD34+ Progenitors, donor1	11545-120B6	7.03	11.04	3.01	2.01	1.00	3.01	2.01	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	10.67	8.99	2.81	2.25	10.67	0.00	2.25	0.56	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	33.82	29.31	13.90	4.51	5.64	2.63	2.63	1.88	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	40.81	39.91	8.12	2.93	4.74	1.35	1.35	1.58	0.23
CD4+ T Cells, donor1	11225-116C1	8.93	7.86	4.64	4.64	15.35	1.07	9.64	0.00	2.86
CD4+ T Cells, donor2	11306-117C1	3.67	5.51	3.67	0.61	34.29	0.61	42.87	0.00	7.35
CD4+ T Cells, donor3	11382-118B5	5.18	5.18	3.05	2.44	17.99	0.91	10.37	0.61	3.05
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	50.03	27.31	19.14	7.15	6.89	0.77	1.79	2.04	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	41.33	32.12	10.56	8.76	23.36	0.67	8.31	1.12	1.80
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	41.39	47.72	14.66	8.91	21.27	0.57	3.74	1.72	1.72
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	7.59	4.27	5.69	8.06	38.88	0.00	11.38	0.00	5.69
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	12.64	7.02	3.51	3.51	42.84	0.00	10.53	1.40	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	6.59	3.30	3.30	3.30	9.89	0.00	13.18	0.00	6.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	57.95	32.23	10.69	4.05	6.36	0.58	1.01	1.59	0.72
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	40.33	25.93	10.85	9.49	13.05	0.85	4.24	0.51	0.85
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	45.94	28.21	10.80	6.61	14.02	1.45	2.90	0.32	1.45
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	10.31	8.07	5.38	2.24	13.00	0.00	2.24	0.45	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	15.37	18.52	5.94	4.54	13.98	0.00	5.59	1.05	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	12.76	8.80	4.40	7.04	3.52	0.00	1.76	0.44	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	94.03	38.79	21.08	6.32	5.48	1.69	0.84	0.00	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	51.73	34.28	12.88	7.27	25.14	1.25	10.39	1.66	2.29
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	76.85	33.75	14.70	4.01	21.72	1.34	7.02	1.67	1.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	10.88	5.44	5.17	4.08	19.31	0.00	4.62	0.54	1.36
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	12.86	13.40	4.29	3.75	11.79	0.54	3.75	0.00	2.14
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	5.38	3.59	1.79	5.38	21.52	0.00	7.17	0.00	3.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	73.06	41.54	14.46	6.68	11.50	2.04	2.04	1.67	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	51.34	36.18	18.41	4.55	8.23	1.52	1.73	2.17	1.52
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	70.19	43.71	13.45	3.99	17.23	2.10	1.68	1.68	1.26
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	13.15	7.58	5.06	4.55	20.22	0.00	4.55	0.00	2.53
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	14.30	10.83	6.07	4.77	20.80	0.43	3.90	0.00	3.03
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	12.20	9.15	4.36	3.49	12.20	1.74	3.05	0.00	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	38.10	36.62	10.89	8.41	50.97	0.49	13.36	1.48	3.96
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	47.08	31.39	7.39	10.16	38.77	0.00	12.00	0.92	3.69
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	46.06	26.52	15.35	6.98	78.17	0.00	18.15	0.00	2.79
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	42.09	20.77	8.31	4.43	15.23	0.83	1.94	1.94	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	64.78	29.94	11.04	5.15	17.91	0.74	5.40	1.72	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	43.12	46.20	7.70	6.16	29.26	1.54	9.24	3.08	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	48.35	30.80	10.74	6.09	56.94	1.43	12.89	0.72	2.15
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	77.56	66.48	12.46	4.15	65.09	0.00	11.08	4.15	2.77
CD8+ T Cells, donor1	11226-116C2	18.99	7.53	1.31	1.96	48.78	0.98	21.61	0.33	4.91
CD8+ T Cells, donor2	11307-117C2	13.14	6.38	1.50	1.13	31.16	1.50	38.29	0.00	7.88
CD8+ T Cells, donor3	11383-118B6	14.64	5.81	4.04	2.52	49.24	1.01	56.81	0.00	9.85
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	34.64	11.93	4.13	1.15	0.92	1.61	0.92	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	34.27	11.26	4.55	0.48	1.20	0.96	0.96	1.20	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	42.68	15.05	6.84	2.46	1.37	1.09	0.55	0.27	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	53.74	15.61	10.81	1.80	0.00	2.40	0.60	1.50	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	32.40	12.24	4.08	0.96	0.00	1.20	0.00	0.24	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	36.84	13.19	5.68	0.68	1.14	1.59	0.00	0.45	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	53.89	14.99	5.00	0.87	1.52	0.87	0.43	0.00	0.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	51.59	10.53	2.90	0.26	1.32	1.58	0.79	0.26	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	37.52	13.37	7.50	0.94	0.23	0.70	0.00	0.00	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	55.24	17.51	10.26	1.51	1.51	0.91	0.91	0.30	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	50.26	18.30	8.42	0.58	2.32	1.45	0.87	0.58	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	58.35	12.26	8.79	1.07	2.13	2.13	0.80	0.53	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	49.03	7.88	3.50	0.00	1.75	0.88	0.44	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	58.29	10.02	7.29	0.46	3.19	0.91	0.46	0.46	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	38.79	10.44	4.48	0.00	2.24	1.49	0.75	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	38.90	11.89	5.40	0.36	1.80	1.08	1.08	0.36	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	30.79	14.67	4.32	0.86	1.44	2.30	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	45.73	13.67	4.24	0.47	1.65	0.47	1.41	0.00	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	65.60	13.63	5.07	0.00	1.90	0.95	0.32	0.00	0.95
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	53.82	16.92	6.15	0.62	1.23	2.15	0.00	0.62	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	45.52	10.58	5.13	1.60	1.60	0.96	0.00	0.96	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	54.31	12.62	6.50	1.53	2.29	1.53	0.00	0.00	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	50.05	13.40	5.52	0.39	3.15	1.97	0.39	0.79	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	45.38	15.13	2.27	1.51	2.27	0.00	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	31.32	10.44	5.62	1.61	8.83	2.41	0.80	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	32.17	8.39	6.29	0.00	6.99	2.10	0.70	0.00	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	38.07	10.02	5.01	1.00	7.01	3.01	3.01	0.00	2.00
Cardiac Myocyte, donor1	11525-119I4	31.07	20.11	0.00	0.00	1.83	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	37.55	10.87	1.98	0.00	1.98	0.99	1.48	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	16.00	10.10	2.32	0.53	0.63	2.32	0.42	0.32	0.00
Chondrocyte - de diff, donor1	11261-116G1	38.83	18.72	0.69	0.35	4.16	4.16	0.35	0.35	0.00
Chondrocyte - de diff, donor2	11338-117F6	38.38	18.83	2.84	0.71	1.07	2.84	0.36	0.71	0.00
Chondrocyte - de diff, donor3	11410-118E6	34.70	21.96	2.39	1.25	2.96	3.64	1.14	1.48	0.11
Chondrocyte - re diff, donor2	11339-117F7	39.39	16.11	7.16	4.48	0.00	0.90	0.00	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	13.35	9.30	0.81	4.45	6.87	3.64	1.21	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	39.94	21.35	17.90	6.08	1.61	2.30	0.80	0.80	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	28.64	13.47	13.25	3.63	0.86	3.63	1.71	0.00	0.86
Ciliary Epithelial Cells, donor3	11399-118D4	25.75	12.57	12.12	3.36	2.30	2.21	1.33	0.62	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	163.69	27.05	12.29	11.74	3.76	3.85	2.48	1.56	0.83
Corneal Epithelial Cells, donor1	11526-119I5	1.32	2.42	0.44	0.22	0.88	0.00	0.22	0.22	0.00
Corneal Epithelial Cells, donor2	11606-120I4	6.83	5.69	1.14	0.00	1.14	1.14	1.14	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	2.56	3.07	0.51	0.26	0.77	0.51	0.77	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	142.97	39.79	6.11	0.50	2.48	6.11	0.50	1.16	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	159.28	35.96	9.46	0.32	3.78	6.62	1.89	0.63	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	55.21	44.86	20.70	3.45	0.00	3.45	0.00	13.80	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	81.96	24.41	4.21	0.11	0.76	3.56	0.97	1.40	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	11.96	14.35	2.73	4.10	7.86	0.34	2.73	0.68	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	9.14	12.40	4.57	3.92	7.18	0.65	0.65	1.31	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	12.10	11.61	1.45	4.84	4.36	0.48	0.97	1.45	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	4.67	7.17	6.67	0.83	0.83	2.33	0.00	0.33	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	4.11	5.28	3.52	0.00	1.17	0.59	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	3.96	2.55	5.66	0.85	0.85	0.85	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	3.54	4.33	4.33	1.18	0.00	2.75	0.39	0.00	0.39
Endothelial Cells - Artery, donor1	11264-116G4	6.40	9.31	5.82	1.45	0.87	2.62	0.00	0.87	0.29
Endothelial Cells - Artery, donor2	11341-117F9	8.00	8.94	6.12	2.12	0.47	3.29	0.24	0.24	0.24
Endothelial Cells - Artery, donor3	11413-118E9	8.94	13.15	3.86	0.70	0.88	1.58	0.00	0.53	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	6.65	8.64	8.42	0.89	1.11	2.44	0.22	0.22	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	7.30	5.48	8.22	1.83	0.30	2.13	0.30	0.61	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	4.79	4.51	8.74	1.13	0.00	1.13	0.00	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	10.70	8.32	7.73	1.19	0.59	4.46	0.00	0.59	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	10.93	13.54	3.64	1.04	2.08	0.52	0.00	1.04	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	1.99	3.97	4.82	1.42	0.85	2.84	0.28	0.43	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	16.81	11.60	11.20	1.20	0.80	3.60	0.00	0.40	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	3.67	3.67	4.72	1.57	1.57	1.57	0.00	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	19.26	21.99	18.26	3.85	0.50	4.10	0.25	0.37	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	7.17	12.60	9.56	2.39	0.43	1.09	1.09	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	5.86	9.40	8.06	1.83	0.37	2.20	0.24	0.49	0.37
Endothelial Cells - Vein, donor1	11267-116G7	6.83	5.69	2.28	3.41	2.28	1.14	1.14	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	8.38	8.38	4.19	0.00	0.70	2.79	0.70	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	5.65	8.32	10.52	1.10	1.10	3.14	0.47	0.47	0.16
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	15.25	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	6.60	0.00	3.30	0.00	3.30	1.65	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	3.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	6.35	4.15	0.00	0.24	0.49	0.49	0.49	0.24	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	6.24	4.16	0.00	0.00	4.16	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	27.91	7.39	2.05	1.23	1.64	2.46	0.82	0.82	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	14.67	7.23	1.09	0.77	0.00	1.86	0.00	0.33	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	15.38	10.18	2.06	1.19	0.00	2.93	0.00	0.33	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	22.07	10.79	2.18	0.49	0.49	1.70	0.49	0.61	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	46.40	16.79	1.64	0.27	15.42	0.82	3.55	0.55	2.32
Fibroblast - Aortic Adventitial, donor2	11326-117E3	13.29	5.80	2.32	1.05	0.63	1.79	0.32	0.32	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	18.44	10.01	1.05	0.00	5.01	1.05	2.90	0.79	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	15.61	12.29	1.33	0.66	0.00	1.99	1.00	0.66	0.00
Fibroblast - Cardiac, donor1	11268-116G8	22.68	8.62	4.08	2.72	3.18	1.81	0.91	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	20.46	6.82	1.52	0.76	3.03	0.76	1.52	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	8.52	4.42	2.52	1.26	0.79	1.73	0.79	0.32	0.16
Fibroblast - Cardiac, donor4	11452-119A3	39.40	20.01	5.15	0.30	0.30	1.52	0.30	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	33.63	17.51	4.70	1.52	0.89	2.79	1.02	0.51	0.38
Fibroblast - Cardiac, donor6	11460-119B2	22.28	13.19	3.49	1.06	0.45	2.27	0.30	0.61	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	20.90	11.39	6.43	2.14	0.27	1.47	0.40	0.67	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	11.22	11.22	5.61	3.02	0.43	0.43	0.43	0.43	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	10.25	19.04	2.93	1.46	0.00	7.32	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	18.68	14.99	2.77	0.92	0.00	1.38	0.00	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	43.25	24.59	5.43	1.02	1.02	2.88	0.00	0.68	0.51
Fibroblast - Dermal, donor1	11269-116G9	12.68	13.85	1.41	0.47	0.70	0.47	0.47	0.47	0.47
Fibroblast - Dermal, donor2	11346-117G5	19.34	13.21	1.89	0.94	0.00	1.42	0.00	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	11.85	13.78	2.18	0.48	1.33	1.45	0.60	0.36	0.00
Fibroblast - Dermal, donor4	11450-119A1	24.53	18.77	4.41	0.90	0.45	1.58	0.34	1.58	0.23
Fibroblast - Dermal, donor5	11454-119A5	33.84	22.50	3.66	1.22	1.40	1.74	0.17	1.57	0.17
Fibroblast - Dermal, donor6	11458-119A9	32.00	24.20	4.55	0.81	0.81	1.95	0.97	1.46	0.32
Fibroblast - Gingival, donor1	11237-116D4	18.95	18.74	2.50	0.42	0.42	0.83	0.00	1.04	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	14.41	12.31	4.72	2.36	0.26	2.88	0.00	0.26	0.00
Fibroblast - Gingival, donor2	11318-117D4	23.59	20.95	3.95	1.84	1.19	1.71	0.79	1.05	0.26
Fibroblast - Gingival, donor3	11394-118C8	24.66	21.46	1.93	1.16	0.29	1.16	0.29	0.77	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	18.70	11.43	2.08	2.08	0.00	5.19	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	10.40	11.10	3.35	1.41	0.88	1.94	0.18	0.53	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	19.33	14.81	2.03	0.94	0.47	1.40	0.16	0.31	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	17.85	12.17	1.35	1.08	0.14	1.35	0.14	0.41	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	6.00	6.35	2.12	0.35	0.00	1.41	0.00	0.71	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	17.26	16.09	2.78	1.61	0.58	1.46	0.44	0.73	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	22.36	20.18	3.14	1.23	0.27	2.86	0.27	0.68	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	25.01	15.69	2.41	1.10	0.55	2.52	0.44	0.77	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	20.54	16.43	2.49	4.11	0.59	5.58	0.15	1.32	0.00
Fibroblast - Lung, donor1	11270-116H1	12.23	9.52	1.36	0.00	0.00	1.36	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	2.98	5.97	2.98	1.49	0.00	1.49	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	17.30	13.72	2.32	0.42	0.63	0.63	0.42	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	6.66	1.67	0.00	0.00	0.00	1.67	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	4.20	0.00	1.40	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	0.28	0.56	0.28	0.00	0.00	0.28	0.00	0.00	0.56
Fibroblast - Mammary, donor1	11540-120B1	17.46	18.67	0.41	1.22	0.00	2.44	0.00	1.22	0.00
Fibroblast - Mammary, donor2	11620-122A9	3.99	0.00	0.00	0.00	0.00	0.00	3.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	11.91	11.91	5.96	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	43.64	27.16	9.50	1.55	0.78	2.52	0.58	0.97	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	28.36	25.03	6.22	2.12	0.00	1.82	0.61	0.61	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	6.43	9.49	2.14	0.61	0.31	0.31	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	11.45	12.59	4.20	0.76	0.38	3.05	0.76	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	25.92	17.28	1.35	2.16	1.62	2.16	0.81	0.27	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	12.29	9.05	1.74	0.70	1.28	1.39	0.23	0.58	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	39.46	21.44	4.53	1.44	1.11	4.86	0.66	0.99	0.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	3.45	2.84	1.42	0.41	0.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	11.36	4.68	2.67	2.00	0.67	1.34	0.67	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	21.35	15.42	5.54	2.37	1.98	0.79	1.19	0.79	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	35.92	16.07	1.98	0.00	1.98	1.39	1.79	1.19	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	25.04	14.03	4.80	3.20	1.24	3.02	0.18	0.53	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	41.78	17.74	2.37	1.58	0.79	4.73	0.39	0.99	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	21.96	12.03	1.50	0.00	3.01	1.20	1.81	1.20	1.20
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	38.54	15.76	3.45	1.08	0.65	2.70	0.22	0.43	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	35.18	14.17	4.05	0.00	3.04	1.27	3.29	2.02	0.76
Fibroblast - skin normal, donor1	11553-120C5	32.32	19.03	3.77	1.31	0.66	2.13	0.00	1.15	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	46.92	21.86	1.40	0.20	5.61	1.40	1.20	1.20	1.00
Fibroblast - skin normal, donor2	11561-120D4	54.25	19.99	4.72	1.21	0.50	2.91	0.20	1.31	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	70.42	28.11	3.32	0.60	4.84	1.21	0.91	0.91	1.51
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	45.23	20.38	5.38	1.33	0.91	3.31	0.41	1.16	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	70.60	22.57	3.93	1.37	1.20	5.64	0.34	0.85	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	13.47	12.15	1.31	0.00	0.33	0.99	0.66	0.99	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	39.63	17.26	5.33	2.13	0.00	3.09	0.11	1.81	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	30.53	18.89	2.53	1.86	1.01	1.52	0.34	1.01	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	25.40	12.55	4.55	2.82	0.00	6.12	0.16	1.88	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	576.15	155.12	0.00	0.00	0.00	44.32	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	17.43	16.56	0.87	0.00	1.74	1.74	0.87	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	7.28	8.84	2.43	1.04	1.21	0.87	0.00	0.69	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	10.41	10.41	3.38	0.26	0.52	1.56	0.00	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	1.79	3.83	1.02	0.26	0.26	0.77	0.00	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	45.17	14.55	26.79	17.61	9.95	0.77	2.30	0.77	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	74.02	28.71	47.22	13.40	6.38	3.19	5.10	1.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	56.48	19.68	79.02	29.10	7.70	3.71	5.99	1.14	1.43
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	11.86	4.96	17.65	17.92	9.65	1.65	5.24	0.28	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	16.67	6.16	19.41	10.96	8.68	1.14	1.83	0.00	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	34.67	12.88	50.13	18.23	6.34	2.18	2.58	0.99	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	12.42	5.82	19.03	14.54	7.93	0.79	5.55	0.53	1.32
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	12.72	3.26	13.37	9.13	10.11	0.98	2.28	0.33	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	62.35	13.71	70.76	15.04	3.54	1.77	3.54	0.88	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	38.16	15.69	47.48	14.70	2.54	2.69	0.71	0.71	0.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	30.17	13.79	31.16	9.36	2.09	2.34	1.11	0.99	0.49
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	40.29	17.46	38.68	9.94	2.42	2.15	1.88	1.88	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	24.28	16.35	22.55	5.82	1.36	1.86	0.87	0.25	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	28.65	17.58	27.82	7.75	0.97	2.49	0.97	0.97	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	41.68	15.04	26.23	7.93	1.02	3.86	1.83	1.42	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	24.42	11.87	20.31	6.16	3.42	1.60	0.91	0.91	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	26.16	12.58	19.68	7.60	1.37	2.12	1.12	0.62	0.50
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	22.29	14.64	20.33	7.87	2.84	2.19	0.87	0.87	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	32.80	10.64	26.00	7.98	6.21	0.89	2.36	0.59	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	22.73	13.19	30.52	9.22	1.27	2.38	1.43	1.11	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	24.35	14.30	20.11	6.03	1.56	1.79	1.34	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	25.20	12.30	26.21	8.47	2.62	0.81	2.42	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	31.72	12.21	32.23	9.33	1.36	1.70	0.85	0.68	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	63.31	15.78	28.82	7.89	2.84	2.04	0.27	0.80	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	29.03	14.26	26.95	7.39	0.52	0.94	0.21	0.73	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	27.32	13.15	20.66	7.51	0.68	0.51	0.51	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	21.58	15.82	26.45	10.07	1.88	1.22	0.33	1.00	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	61.81	15.64	27.95	9.23	4.33	2.16	1.16	1.08	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	53.70	18.17	26.34	8.78	3.68	1.02	0.41	1.43	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	22.49	16.09	21.87	8.25	4.75	1.65	1.24	0.62	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	24.56	14.30	27.67	10.15	1.61	0.92	1.27	0.69	0.81
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	26.52	16.68	16.84	6.84	2.33	2.17	1.83	1.17	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	23.15	13.89	17.63	11.02	3.31	0.22	1.54	1.32	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	25.58	17.10	21.65	8.86	1.23	1.48	1.11	1.35	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	25.12	12.48	20.26	7.29	3.08	0.97	1.95	0.65	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	25.34	14.11	21.49	7.38	4.17	0.96	0.00	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	19.14	15.92	18.86	7.86	1.80	1.14	0.76	0.76	0.76
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	23.88	16.61	15.50	5.69	1.11	1.90	1.11	1.42	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	27.06	12.47	14.29	7.60	2.13	1.22	0.30	0.91	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	23.21	19.44	16.62	7.11	1.88	1.78	0.52	0.42	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	22.18	16.03	19.32	5.49	2.85	0.66	2.42	1.32	0.88
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	27.21	15.99	14.03	8.42	2.52	1.96	2.81	0.28	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	19.26	16.02	12.68	4.17	0.19	1.94	0.09	1.20	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	29.15	23.26	13.37	4.01	1.87	1.87	1.07	1.34	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	18.05	16.52	12.39	4.74	0.92	0.92	1.38	0.77	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	22.41	18.39	13.34	4.53	0.39	2.07	0.78	0.65	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	24.94	22.50	16.81	8.40	0.54	1.36	0.00	1.90	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	27.47	16.59	15.85	6.08	2.77	1.47	1.47	1.84	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	24.34	19.08	13.16	5.70	3.95	1.32	0.88	1.10	0.88
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	16.86	11.90	16.86	7.93	0.00	1.98	0.00	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	25.72	13.59	12.00	5.14	1.58	2.11	0.53	0.66	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	23.61	14.73	10.69	6.66	6.05	1.21	0.20	0.61	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	44.73	18.55	14.74	7.37	0.00	2.29	0.00	1.27	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	67.28	24.68	72.06	14.93	0.80	2.99	0.00	1.59	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	29.27	19.41	38.36	15.72	0.92	1.69	1.39	0.92	0.77
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	44.60	20.87	66.69	21.07	0.61	3.89	1.02	0.41	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	53.51	23.78	41.62	8.76	20.03	1.25	3.76	0.94	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	47.47	20.91	44.64	14.13	8.48	2.26	1.98	1.41	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	31.36	15.22	33.67	9.69	3.23	2.77	1.38	1.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	49.50	12.37	29.70	4.95	2.47	2.47	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	36.36	10.83	42.55	11.60	3.09	2.32	0.00	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	22.46	16.04	38.51	12.84	1.60	1.60	1.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	20.87	6.96	45.21	0.00	10.43	3.48	5.22	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	30.92	10.42	40.68	11.07	2.60	2.93	0.33	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	35.00	14.00	50.65	9.06	1.65	0.82	0.41	0.82	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	23.33	3.33	29.99	10.00	10.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	28.80	12.02	40.83	8.95	2.52	1.96	1.96	0.56	1.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	30.07	9.48	41.84	8.82	1.31	1.31	0.65	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	21.81	5.87	30.20	8.39	4.19	3.36	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	27.04	7.95	35.31	9.86	3.18	2.23	1.59	0.32	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	28.19	11.89	42.80	12.57	2.04	2.72	0.34	0.34	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	27.15	6.26	39.67	18.79	8.35	0.00	6.26	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	22.34	9.16	37.23	11.45	3.44	1.72	0.57	1.72	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	22.79	7.99	27.82	7.40	3.26	0.89	1.78	0.30	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	40.66	8.47	27.11	11.86	6.78	1.69	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	42.66	14.50	35.21	6.63	1.24	3.31	0.83	0.83	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	24.62	8.28	26.23	7.13	3.45	0.92	0.69	0.23	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	21.07	10.54	21.07	5.27	21.07	0.00	0.00	0.00	10.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	22.30	10.38	36.52	5.77	5.77	2.31	0.77	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	31.29	7.82	22.82	8.80	4.56	0.65	1.63	0.00	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	35.45	10.03	25.42	8.03	8.69	0.67	0.67	2.68	2.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	31.98	5.78	31.98	10.40	2.70	0.77	0.77	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	26.36	7.53	20.88	8.90	5.14	1.71	0.68	0.34	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	32.30	7.45	9.94	2.48	12.42	0.00	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	17.93	12.27	25.48	11.80	1.89	1.42	0.94	1.42	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	29.57	13.28	28.97	14.48	5.43	0.60	1.21	0.60	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	37.64	12.72	22.38	12.72	7.63	2.03	0.51	1.53	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	25.92	8.38	20.34	10.37	2.79	0.40	1.60	0.40	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	36.51	8.88	27.63	8.88	8.88	0.49	3.45	0.00	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	30.69	3.54	15.35	8.26	15.35	2.36	7.08	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	30.92	10.50	29.17	14.59	7.58	1.75	3.50	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	25.89	5.71	26.33	13.61	3.51	0.88	0.44	0.00	2.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	22.04	5.93	14.41	11.02	11.87	0.85	2.54	0.00	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	26.26	11.94	18.50	5.97	5.97	0.00	2.98	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	36.88	13.10	17.95	6.79	2.43	0.49	0.00	2.43	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	19.40	7.99	5.71	0.00	0.00	1.14	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	11.23	5.41	4.57	2.49	0.83	1.25	0.42	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	12.37	16.87	2.25	0.00	2.25	1.12	2.25	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	11.73	17.13	2.22	1.27	1.27	1.90	1.27	0.63	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	11.70	14.62	3.34	0.00	0.42	2.92	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	192.40	25.88	8.36	1.74	1.86	3.48	1.51	0.46	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	150.74	29.37	10.13	1.52	2.87	4.05	2.03	1.35	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	118.98	26.39	3.87	0.91	2.50	3.41	0.46	0.46	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	175.55	27.22	7.76	1.20	2.84	3.72	2.30	0.77	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	162.69	24.50	8.17	1.07	2.15	3.01	1.29	0.64	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	106.13	22.39	4.09	0.65	2.37	1.29	2.58	0.86	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	172.86	26.90	6.60	1.12	4.61	3.49	2.86	1.49	0.87
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	149.76	25.56	11.15	1.54	5.49	3.77	1.72	1.03	1.03
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	104.76	23.71	4.81	0.64	2.24	1.60	1.60	1.28	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	10.07	8.95	7.28	2.24	0.56	1.12	0.56	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	3.90	6.06	1.30	0.43	0.43	0.43	1.30	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	5.29	10.58	5.29	5.29	0.00	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	10.93	4.94	3.53	1.76	1.76	2.12	0.00	0.71	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	5.81	3.63	1.45	2.18	2.18	0.00	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	25.53	13.64	1.75	0.35	0.70	0.52	1.40	0.17	0.35
Hepatocyte, donor1	11523-119I2	595.62	62.95	8.47	0.00	10.90	16.95	3.63	0.00	1.21
Hepatocyte, donor2	11603-120I1	503.12	57.10	15.08	0.00	4.31	17.24	1.08	2.15	0.00
Hepatocyte, donor3	11684-122I1	265.66	30.06	11.66	0.61	6.75	14.11	2.45	2.45	2.45
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	139.48	11.89	31.64	3.50	0.35	2.80	0.87	0.00	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	14.96	9.19	9.06	1.92	0.41	0.96	0.00	0.41	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	0.00	3.18	0.00	3.18	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	0.00	0.00	0.00	6.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	0.00	2.77	4.15	0.00	2.77	0.00	4.15	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	2.50	5.01	0.00	2.50	0.00	0.00	5.01	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	0.00	2.56	0.00	0.00	2.56	0.00	5.13	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	0.00	4.57	0.00	0.00	0.00	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	0.00	0.00	0.00	1.62	1.62	0.00	0.00	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	0.00	3.33	0.00	1.67	5.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	3.63	0.00	0.00	0.00	0.00	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	1.32	3.97	3.97	0.00	2.65	0.00	5.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	2.22	1.11	3.33	0.00	1.11	0.00	2.22	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	5.24	0.00	5.24	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	1.26	0.00	1.26	0.00	0.63	0.00	0.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	1.55	3.09	1.55	0.00	0.00	0.00	0.00	0.00	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	14.63	0.00	0.00	14.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	1.29	2.58	1.29	0.65	1.29	0.00	0.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	3.22	0.00	0.00	0.00	4.83	3.22	0.00	0.00	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	11.95	0.00	11.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	1.63	0.81	2.44	0.00	0.81	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	4.20	0.84	0.42	0.84	1.68	0.84	1.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	14.37	0.00	0.00	14.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	1.61	0.80	3.21	0.00	1.61	0.00	0.80	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	0.00	0.92	0.92	0.92	0.92	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	15.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	1.42	0.94	2.36	1.42	1.42	0.00	0.00	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	0.91	0.00	0.91	0.00	1.81	0.00	2.72	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	29.48	0.00	0.00	0.00	14.74
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	1.08	3.23	2.15	3.23	2.15	0.00	1.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	0.00	0.00	1.27	2.54	1.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	32.86	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	5.74	1.91	1.28	1.91	0.00	0.00	0.64	0.00	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	1.82	3.65	1.82	0.00	0.00	0.00	0.00	1.82	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	15.80	0.00	15.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	0.71	2.14	1.43	1.43	1.43	0.00	3.57	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	0.00	0.00	0.00	0.00	0.00	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	20.85	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	1.85	1.23	0.93	2.16	1.23	0.00	0.00	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	1.76	0.00	3.51	3.51	0.00	0.00	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	3.14	3.14	0.00	3.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	0.70	0.00	0.70	0.70	2.09	0.00	1.39	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	0.00	4.43	2.21	0.00	4.43	0.00	0.00	0.00	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	0.00	3.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	1.74	1.74	1.74	0.87	0.87	0.00	0.87	0.00	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	2.25	6.75	2.25	2.25	2.25	0.00	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	0.00	0.00	0.00	3.48	0.00	0.00	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	4.27	4.27	2.13	4.27	7.47	0.00	4.27	0.00	4.27
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	0.00	0.00	0.00	1.39	1.39	1.39	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	0.00	0.00	0.00	0.00	0.00	0.00	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	0.92	0.00	0.00	0.00	1.84	0.00	0.92	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	3.03	6.05	6.05	0.00	3.03	0.00	9.08	0.00	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	0.00	6.21	12.42	18.63	0.00	12.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	7.40	3.17	4.23	2.11	7.40	0.00	3.17	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	12.73	8.65	0.90	0.33	0.16	0.73	0.16	0.00	0.16
Keratinocyte - epidermal, donor2	11349-117G8	1.17	0.00	0.00	0.00	2.34	0.00	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	0.38	0.66	0.09	0.19	0.76	0.09	1.04	0.19	0.00
Keratinocyte - oral, donor1	11251-116E9	52.33	41.09	4.31	0.91	0.45	1.93	0.45	2.04	0.00
Keratocytes, donor1	11527-119I6	17.54	13.75	1.38	1.03	1.72	0.34	0.34	0.69	0.00
Keratocytes, donor2	11607-120I5	10.55	5.86	3.52	0.00	0.00	1.17	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	23.32	7.71	2.37	0.20	1.98	0.99	0.79	0.00	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	4.40	0.00	0.00	4.40	4.40	0.00	2.20	0.00	4.40
Lens Epithelial Cells, donor1	11529-119I8	15.10	19.42	3.24	3.24	0.00	1.08	2.16	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	22.61	15.69	14.42	6.00	1.27	2.54	0.35	0.81	0.12
Lens Epithelial Cells, donor3	11690-122I7	13.72	6.36	9.18	2.32	0.71	1.92	0.40	0.61	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	7.59	8.66	7.11	2.13	1.19	2.37	0.36	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	2.51	7.26	5.30	1.95	0.84	1.67	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	4.41	6.93	5.67	1.73	0.47	2.83	0.16	0.16	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	3.76	10.22	3.23	0.00	1.08	1.61	0.54	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	2.52	5.99	3.47	0.95	0.95	0.95	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	3.56	5.28	6.04	1.62	0.43	1.62	0.11	0.43	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	6.98	8.21	6.98	1.64	0.82	3.69	0.00	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	4.05	4.30	1.77	1.26	1.26	2.02	0.00	0.51	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	3.66	6.19	4.36	2.53	0.70	3.10	0.42	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	7.52	5.14	7.52	1.19	0.00	2.37	0.00	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	3.68	5.62	4.27	2.33	0.39	1.74	0.58	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	2.22	5.00	4.07	0.74	0.56	2.22	0.00	0.37	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	3.83	5.57	6.62	1.05	0.35	3.14	0.35	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	5.49	5.96	5.49	1.91	0.72	2.15	0.24	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	3.71	6.18	5.77	1.51	0.41	2.20	0.41	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	5.85	8.01	3.70	0.62	0.00	2.16	0.00	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	4.68	5.61	4.05	0.94	0.94	1.56	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	2.56	5.49	4.57	3.11	1.10	2.74	0.18	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	7.24	8.56	5.92	1.32	0.33	0.99	0.00	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	2.05	6.74	3.81	2.05	0.29	2.05	0.29	0.59	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	1.74	2.74	3.49	1.74	0.50	1.00	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	4.85	9.70	2.42	1.45	0.00	2.42	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	2.42	5.66	5.39	1.62	0.00	1.62	0.81	0.27	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	4.24	7.42	3.78	1.36	0.61	1.82	0.15	0.61	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	8.29	5.70	6.22	1.56	0.52	0.52	0.00	0.00	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	2.93	5.65	2.30	1.88	0.84	1.05	0.00	0.00	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	5.71	5.11	6.32	2.11	0.45	2.26	0.00	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	8.94	4.13	4.13	0.00	0.69	2.75	0.00	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	3.20	7.90	3.20	1.69	0.75	0.38	0.38	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	5.09	5.94	5.30	1.70	0.32	1.48	0.42	0.32	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	8.24	8.72	3.88	0.00	0.00	0.97	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	6.95	5.29	4.30	0.33	0.00	1.32	0.00	0.00	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	4.96	5.45	3.47	1.36	0.25	1.86	0.62	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	8.89	7.77	9.26	0.74	1.11	3.33	1.11	1.11	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	6.42	6.42	3.21	1.24	1.24	2.47	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	4.12	4.26	3.99	1.24	0.00	1.65	0.14	0.14	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	6.43	5.79	4.50	1.61	0.00	1.61	0.96	0.64	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	3.35	7.00	4.56	0.30	0.30	1.22	0.00	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	6.02	6.16	6.02	1.26	0.42	1.82	0.14	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	5.69	6.76	4.27	1.07	0.36	1.07	0.36	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	7.27	4.36	0.48	0.97	0.00	0.00	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	3.89	7.62	3.89	0.31	0.31	1.40	0.62	0.00	0.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	7.16	8.24	6.45	0.36	2.15	2.51	0.36	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	6.21	7.51	1.63	2.29	1.31	2.61	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	2.83	4.47	3.53	1.18	0.24	1.88	0.00	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	8.29	10.02	5.94	1.73	0.50	2.85	0.00	0.62	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	3.59	5.63	1.79	0.26	1.02	0.77	0.00	0.26	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	5.07	3.28	2.39	1.19	0.00	2.39	0.30	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	9.06	2.27	6.80	2.27	0.00	2.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	3.84	2.30	4.60	5.37	1.53	0.77	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	4.45	2.23	5.94	2.23	0.00	0.74	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	2.96	3.81	7.19	2.12	1.69	0.00	1.69	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	4.92	4.22	4.22	1.41	0.70	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	2.80	0.00	3.74	2.80	0.93	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	6.18	1.03	4.12	5.15	1.55	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	5.95	4.76	4.76	1.19	1.19	0.00	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	5.20	4.07	6.33	3.39	2.71	0.00	0.90	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	6.11	2.04	7.56	5.82	0.58	0.87	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	3.60	2.25	7.65	3.15	0.90	0.45	0.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	6.91	4.88	7.45	3.12	0.81	0.95	0.54	0.14	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	5.65	1.54	4.62	3.59	2.05	0.51	1.03	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	3.53	2.47	11.64	2.82	0.35	0.71	0.00	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	2.00	2.67	4.66	2.00	2.67	0.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	7.64	3.57	7.13	4.08	3.06	0.00	1.53	0.51	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	5.87	1.87	6.40	5.07	1.07	0.53	0.27	0.53	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	5.29	5.29	10.77	2.65	0.94	0.38	0.00	0.19	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	4.29	1.23	5.52	4.29	3.68	1.23	0.61	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	4.89	8.15	6.52	0.82	0.82	0.82	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	5.00	5.00	8.95	3.75	0.83	0.83	0.42	0.21	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	6.17	2.52	8.41	2.52	0.28	1.12	0.56	0.00	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	5.15	1.03	10.30	1.03	0.00	1.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	6.10	2.61	7.26	4.35	0.00	0.87	0.29	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	4.48	3.59	7.77	4.78	0.90	0.30	1.20	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	3.32	1.11	8.30	2.77	0.55	0.00	0.55	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	3.53	4.24	3.18	1.77	1.41	0.00	1.06	0.71	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	4.43	4.79	8.11	2.95	0.00	0.74	1.11	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	8.06	3.45	6.91	2.30	0.00	1.15	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	7.68	4.22	10.36	2.69	1.54	0.77	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	4.53	4.53	11.89	2.26	2.83	0.00	0.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	2.46	2.46	7.38	5.74	0.82	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	5.42	4.97	8.59	2.26	1.36	0.00	1.36	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	5.03	4.31	5.75	5.03	0.72	0.72	0.72	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	2.99	2.99	8.22	3.73	0.00	1.49	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	6.69	2.97	7.06	4.09	1.49	0.37	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	5.60	1.72	7.75	3.45	0.86	0.86	1.29	0.00	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	2.57	2.57	6.85	2.57	2.57	1.71	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	5.00	2.67	7.33	3.66	1.00	1.00	1.33	0.33	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	6.64	4.22	6.64	4.22	2.41	0.00	3.02	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	3.55	4.27	4.98	4.27	2.84	0.00	0.71	0.00	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	4.81	3.78	5.16	4.47	0.34	0.69	1.72	0.34	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	4.83	0.00	5.90	0.00	1.07	1.61	2.15	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	5.39	4.71	4.71	2.02	1.35	0.67	1.35	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	5.56	2.22	6.67	2.96	1.11	0.74	1.11	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	4.65	8.14	5.81	1.16	2.33	0.00	0.00	1.16	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	3.17	2.12	5.29	3.17	1.06	1.06	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	6.40	4.40	6.80	4.00	2.40	0.80	1.20	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	5.81	3.63	8.72	2.91	0.00	0.73	1.45	0.73	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	5.37	4.60	5.37	6.90	3.07	0.77	1.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	5.92	1.97	6.91	1.48	3.45	0.49	0.99	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	6.59	3.76	7.53	1.88	0.94	0.00	1.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	2.51	3.52	8.55	2.01	3.52	0.00	1.51	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	4.06	3.15	6.31	3.60	2.25	0.90	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	6.88	0.00	5.16	0.00	1.72	0.00	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	3.56	2.67	6.68	3.12	3.12	0.45	1.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	3.52	3.13	6.65	1.56	1.17	0.39	0.78	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	2.64	4.62	9.24	1.32	2.64	1.32	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	6.75	2.59	6.75	3.63	1.04	1.56	1.56	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	5.25	3.50	7.00	6.13	1.31	1.75	0.88	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	3.91	1.12	10.06	2.24	1.12	0.00	1.12	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	4.86	2.21	4.86	1.77	1.32	0.44	0.88	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	6.17	2.31	8.87	3.86	1.93	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	6.08	3.04	9.62	3.04	1.52	1.01	0.00	0.00	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	5.77	0.96	6.73	0.48	0.48	0.00	0.00	0.00	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	7.55	2.39	4.77	3.18	1.99	0.80	1.99	0.40	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	6.68	1.22	4.25	3.04	1.22	1.82	0.61	0.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	5.53	2.08	5.53	1.38	1.38	1.38	0.69	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	3.42	1.90	7.60	3.42	2.66	0.76	0.00	0.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	8.26	2.58	4.13	1.03	1.55	0.52	0.52	1.03	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	4.84	1.81	4.23	0.00	0.60	1.21	0.00	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	4.44	2.54	8.56	3.49	0.95	1.27	0.95	0.32	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	5.86	3.73	5.86	2.13	1.07	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	8.05	4.02	5.75	3.45	1.15	0.00	0.57	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	5.14	1.54	4.63	1.54	1.03	1.54	1.03	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	5.66	2.12	6.37	4.24	0.00	0.71	0.00	0.71	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	6.81	2.84	8.51	1.13	0.57	0.57	1.70	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	4.58	3.74	7.49	2.08	3.33	0.42	1.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	7.83	2.35	7.83	3.13	0.00	0.78	0.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	5.85	0.84	8.35	1.67	0.84	0.00	0.42	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	1.86	3.25	3.72	3.25	1.39	1.39	0.46	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	8.03	3.35	7.36	2.68	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	5.35	0.53	4.81	1.07	0.00	0.53	0.53	0.00	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	5.66	5.66	6.47	0.81	1.62	1.21	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	11.01	2.75	3.67	3.67	1.84	0.92	0.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	2.67	0.00	8.00	2.67	0.89	1.78	0.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	3.99	3.42	5.13	2.85	0.57	0.57	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	9.20	3.07	3.07	2.30	1.53	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	4.38	1.64	4.92	2.19	0.55	1.64	1.09	1.09	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	2.67	3.12	6.24	4.01	0.89	0.89	0.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	10.14	4.68	7.02	3.38	1.04	0.26	1.04	0.52	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	4.64	1.33	4.64	0.66	0.66	1.33	0.00	0.66	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	4.16	4.16	8.31	2.08	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	24.61	26.44	12.99	4.10	0.23	1.82	0.23	0.91	0.46
Macrophage - monocyte derived, donor2	11313-117C8	105.70	38.17	6.24	0.37	0.73	4.04	0.55	2.57	0.18
Macrophage - monocyte derived, donor3	11389-118C3	35.79	21.63	6.69	2.10	0.92	2.36	1.05	1.05	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	23.90	21.77	2.12	0.53	0.53	1.06	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	38.98	20.12	6.81	0.48	0.48	3.80	1.11	0.32	0.16
Mallassez-derived cells, donor3	11930-125I4	25.30	14.87	2.64	0.83	0.97	1.95	0.28	0.14	0.00
Mammary Epithelial Cell, donor1	11273-116H4	25.91	25.81	2.49	0.60	0.80	2.99	0.30	0.80	0.00
Mammary Epithelial Cell, donor2	11350-117G9	22.87	17.95	0.58	0.58	0.29	1.16	0.29	0.58	0.00
Mammary Epithelial Cell, donor3	11422-118F9	4.99	8.73	1.50	0.25	0.75	0.75	0.25	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	38.64	16.95	11.52	4.75	0.00	0.00	0.00	2.71	0.68
Mast cell, donor1	11563-120D6	21.52	20.22	10.60	4.11	2.27	1.08	1.19	2.05	0.00
Mast cell, donor2	11565-120D8	9.81	15.16	7.43	2.67	4.75	3.27	1.49	1.19	0.89
Mast cell, donor3	11566-120D9	10.81	16.43	8.33	2.70	4.05	3.83	1.13	1.13	0.00
Mast cell, donor4	11567-120E1	9.04	12.94	4.43	3.90	2.84	3.19	0.35	1.06	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	33.71	32.27	11.87	2.66	1.00	2.88	0.89	1.00	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	32.69	12.26	2.33	1.17	2.92	0.00	1.75	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	26.16	35.33	12.62	4.70	5.97	1.26	3.10	2.18	0.23
Mast cell, expanded, donor8	11941-126A6	17.24	22.09	7.87	3.85	2.68	1.00	1.51	1.17	0.84
Melanocyte - dark, donor1	11502-119F8	5.17	7.96	7.96	2.59	0.50	1.59	0.10	0.40	0.10
Melanocyte - dark, donor2	11582-120F7	35.30	16.27	4.85	0.00	1.38	1.73	1.38	0.00	0.69
Melanocyte - dark, donor3	11663-122F7	29.70	30.86	12.89	5.65	0.72	2.32	0.22	1.59	0.07
Melanocyte - light, donor1	11274-116H5	18.10	14.10	2.82	0.47	0.71	0.71	0.24	0.47	0.00
Melanocyte - light, donor2	11351-117H1	11.60	13.65	2.73	2.73	0.00	0.68	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	25.15	9.54	5.20	2.60	0.00	1.73	1.73	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	13.22	16.56	9.06	2.08	0.94	1.15	0.52	1.25	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	24.47	21.52	7.53	4.03	1.34	0.81	0.81	0.81	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	15.00	16.61	5.36	3.75	0.27	0.27	0.80	0.54	0.00
Meningeal Cells, donor1	11493-119E8	12.90	9.92	11.29	2.61	0.12	0.99	0.00	0.62	0.00
Meningeal Cells, donor2	11573-120E7	12.76	7.92	5.72	3.96	0.44	0.88	0.00	0.00	0.00
Meningeal Cells, donor3	11654-122E7	34.48	21.84	12.31	3.67	0.41	1.55	0.08	0.57	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	40.78	23.95	9.70	2.00	0.29	2.57	0.86	0.86	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	10.06	4.13	5.84	1.81	1.21	1.51	0.00	0.10	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	7.88	2.63	2.63	0.00	1.31	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	7.85	3.92	1.31	2.62	2.62	1.31	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	27.99	19.38	2.15	1.44	0.72	0.00	1.44	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	6.78	4.45	4.24	2.54	0.00	1.48	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	3.52	3.52	2.01	2.01	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	16.92	11.65	2.86	1.10	1.10	1.54	0.44	0.44	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	11.69	7.31	1.46	0.73	0.00	0.00	0.73	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	11.25	6.34	2.25	0.41	2.05	1.02	0.20	0.41	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	27.15	12.88	9.42	3.74	0.55	3.32	0.42	1.52	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	5.95	4.09	0.74	1.86	0.74	0.00	0.74	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	14.08	7.11	4.21	2.63	0.53	1.97	0.39	0.26	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	11.28	7.42	2.37	1.19	0.30	0.30	0.30	0.89	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	0.00	0.00	0.00	0.00	0.00	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	6.40	8.33	3.20	1.28	0.00	0.64	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	56.00	23.04	1.42	1.06	0.35	1.42	0.71	1.06	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	12.82	8.13	4.38	3.13	0.63	0.94	0.00	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	18.87	14.51	2.90	0.00	0.73	1.45	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	90.69	21.21	4.77	1.86	0.80	4.51	0.27	1.06	0.27
Mesothelial Cells, donor2	12156-128G5	81.58	12.01	1.00	0.00	2.00	4.00	0.00	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	37.00	12.50	2.89	0.94	0.65	2.10	0.22	0.94	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	28.36	6.75	2.70	1.35	1.35	4.05	0.00	2.70	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	34.72	14.28	5.66	0.74	0.25	2.46	0.00	1.23	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	62.13	22.97	5.59	2.06	0.00	2.06	0.29	1.77	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	10.37	10.37	0.00	0.00	3.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	30.99	14.26	4.96	1.55	0.31	1.55	0.62	1.55	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	65.55	18.67	3.32	1.24	0.41	2.28	0.41	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	4.63	9.26	0.00	0.00	0.00	4.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	33.79	13.76	6.26	0.50	0.00	2.25	0.50	1.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	54.00	13.50	3.72	2.33	2.33	2.33	0.47	1.86	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	34.14	13.82	5.69	0.81	0.20	3.25	0.00	0.41	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	57.02	16.63	3.56	1.19	0.40	2.38	0.00	0.79	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	23.89	9.73	7.96	0.88	0.88	0.00	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	81.69	24.70	7.22	0.76	1.14	1.90	0.76	2.66	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	6.58	5.26	5.26	1.32	0.00	2.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	21.65	13.37	4.46	0.42	0.21	1.91	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	22.10	8.29	0.00	0.00	0.00	0.92	0.92	1.84	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	12.82	11.33	2.09	0.30	0.89	1.19	0.00	1.49	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	10.06	18.44	1.68	0.00	0.00	0.00	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	15.05	14.30	5.52	0.75	0.75	0.75	0.00	1.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	53.95	22.58	4.75	0.95	0.24	2.38	0.24	0.71	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	4.98	6.08	1.66	0.55	0.00	0.55	0.00	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	30.39	12.89	4.14	0.23	0.46	0.92	0.00	0.46	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	52.80	18.72	4.42	1.05	0.00	2.52	0.00	0.63	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	18.14	10.40	2.45	0.61	0.20	0.82	0.00	1.43	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	26.60	15.45	4.51	0.43	0.43	0.86	0.43	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	44.68	18.01	4.89	0.44	0.22	1.78	0.00	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	19.05	11.17	3.29	0.00	0.22	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	25.35	10.14	2.03	0.00	0.00	1.01	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	3.31	1.66	1.66	0.00	0.00	0.00	0.00	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	20.66	8.70	2.17	0.00	0.27	1.09	0.00	0.82	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	39.11	14.41	4.12	0.59	0.29	2.06	0.59	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	8.72	6.54	1.09	1.09	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	20.66	11.53	3.84	0.96	1.44	1.44	0.00	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	53.63	14.41	2.40	0.00	0.80	0.80	0.00	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	5.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	19.52	10.01	1.50	0.50	1.00	0.50	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	80.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	0.00	2.04	2.04	0.00	0.00	0.00	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	19.27	8.76	1.31	0.00	0.44	0.88	0.88	1.31	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	6.62	8.83	0.00	0.00	0.00	3.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	4.48	0.64	1.92	0.00	0.64	0.00	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	25.54	10.66	1.24	0.50	0.74	0.74	0.00	0.74	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	9.05	6.96	1.39	0.70	0.00	0.70	0.00	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	0.00	2.21	2.21	0.00	0.00	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	18.80	9.57	2.39	0.68	0.34	1.03	0.34	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	17.07	8.31	0.44	0.00	0.00	1.75	0.00	0.44	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	2.84	3.55	1.07	0.00	0.00	0.36	0.00	0.36	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	22.72	10.66	1.96	0.00	0.28	0.56	0.00	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	21.20	10.81	2.49	0.42	0.00	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	3.50	1.75	1.17	0.58	0.00	1.17	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	16.29	8.75	1.21	0.60	0.60	0.90	0.30	0.60	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	29.63	14.61	4.17	1.25	0.42	1.67	0.42	1.25	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	9.24	5.54	0.00	1.85	0.00	0.00	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	25.04	17.64	4.55	0.57	0.00	0.00	0.00	1.71	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	6.77	5.25	2.07	0.41	0.14	0.55	0.00	0.28	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	13.99	13.73	3.11	0.52	0.52	0.78	0.00	0.52	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	21.02	9.44	2.57	0.00	0.00	0.86	0.00	1.72	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	0.64	5.08	1.91	2.54	0.00	0.64	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	6.14	6.14	2.40	0.80	0.27	0.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	32.33	16.46	4.49	2.39	0.60	0.90	0.00	1.50	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	4.38	5.65	2.83	1.13	0.14	0.28	0.00	0.57	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	17.52	12.10	1.91	0.64	0.32	0.00	0.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	29.85	17.47	5.09	1.55	0.22	1.33	0.22	1.77	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	4.55	6.07	2.28	1.90	0.00	0.76	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	9.09	8.52	3.69	0.85	0.85	0.28	0.00	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	31.95	15.24	3.93	0.25	0.25	0.98	0.00	1.72	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	3.26	4.56	3.26	0.00	0.00	0.00	0.65	1.30	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	10.58	11.17	3.53	1.76	0.00	0.29	0.29	1.18	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	32.00	19.61	4.61	2.88	0.58	1.15	0.00	1.44	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	24.73	7.42	3.71	2.47	0.00	0.82	0.00	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	8.93	12.51	3.57	0.60	0.00	0.30	0.00	0.89	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	11.30	0.00	0.00	3.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	23.17	24.95	5.35	0.00	1.78	1.78	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	19.39	26.94	7.56	1.64	0.00	2.63	0.33	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	44.18	33.66	5.26	1.05	5.26	3.16	1.05	2.10	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	15.02	20.76	7.51	1.58	0.40	0.99	0.00	1.98	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	24.21	32.60	4.66	1.86	0.93	2.79	0.93	2.79	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	19.53	18.03	9.01	3.38	0.00	2.63	0.38	1.50	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	44.48	28.50	7.99	1.33	1.07	1.86	0.00	1.33	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	19.79	18.32	7.35	1.58	0.23	1.47	0.11	2.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	17.68	11.05	8.10	0.00	0.74	0.74	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	17.59	21.99	6.60	1.47	0.00	2.20	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	40.45	24.89	10.89	0.00	0.00	0.00	0.00	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	13.90	18.71	3.74	1.07	0.00	1.07	0.53	1.60	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	11.59	7.73	3.86	0.00	0.00	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	16.16	21.21	7.07	1.01	1.01	1.01	1.01	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	21.93	26.14	6.32	1.26	0.00	1.26	0.00	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	8.17	1.36	4.09	0.00	1.36	1.36	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	22.89	5.72	1.27	0.00	3.18	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	21.06	10.53	0.00	0.00	4.86	0.00	0.81	0.00	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	12.08	9.06	3.02	1.51	3.02	1.51	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	17.13	5.71	5.71	5.71	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	55.46	0.00	3.26	0.00	0.00	0.00	0.00	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	33.27	19.01	0.00	0.00	4.75	0.00	0.00	9.50	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	12.55	0.00	12.55	0.00	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	21.76	8.40	6.68	1.51	0.65	4.09	0.22	0.43	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	13.59	5.75	7.84	2.09	1.05	1.05	0.52	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	11.35	12.01	1.33	2.00	0.00	2.67	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	7.93	4.59	1.25	0.42	0.00	2.50	0.00	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	26.43	14.83	7.80	1.14	0.38	6.65	0.00	0.19	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	15.96	11.17	1.60	1.60	0.00	3.19	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	6.12	4.76	0.00	0.00	0.00	0.68	0.00	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	42.27	33.08	14.70	1.84	0.00	1.84	0.00	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	8.37	5.86	0.84	2.51	1.26	0.42	0.00	1.26	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	10.92	9.07	1.86	1.39	0.46	1.63	0.00	0.23	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	6.76	6.49	1.62	1.35	0.27	2.43	0.00	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	16.40	14.30	2.73	1.05	0.63	1.89	0.42	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	55.67	33.40	22.27	0.00	0.00	33.40	0.00	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	11.91	12.41	2.48	0.00	0.50	0.99	0.50	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	12.45	7.31	2.71	3.52	0.27	3.25	0.00	0.81	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	7.93	7.71	1.36	1.13	0.00	1.13	0.23	0.45	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	5.88	5.72	1.80	1.47	0.16	3.27	0.33	0.33	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	19.14	12.58	2.55	1.64	0.00	1.64	1.09	0.73	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	10.61	12.73	1.06	0.00	0.53	1.06	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	14.41	10.81	1.80	1.20	0.60	1.80	0.60	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	21.66	10.83	9.19	3.94	0.66	7.88	0.33	0.66	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	6.83	6.34	0.98	0.98	0.49	0.81	0.00	0.16	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	15.17	8.64	2.47	1.23	0.53	1.59	0.18	0.35	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	11.25	11.95	0.70	2.11	0.00	0.00	0.00	1.41	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	8.27	8.27	1.38	0.00	0.92	3.22	0.46	0.46	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	11.25	7.07	1.93	1.93	1.29	4.18	0.64	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	26.90	8.97	7.59	1.38	0.00	11.38	0.00	0.34	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	22.76	7.59	32.87	2.53	0.00	20.23	0.00	5.06	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	12.03	9.36	1.78	0.22	0.00	2.45	0.00	0.67	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	13.97	8.04	0.42	1.27	1.27	0.85	0.00	0.85	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	9.02	5.70	2.61	0.71	0.00	2.61	0.71	0.00	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	10.30	9.44	0.86	1.29	1.29	1.29	0.00	0.43	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	90.28	54.17	18.06	0.00	0.00	27.08	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	7.66	5.33	1.33	0.67	0.67	2.67	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	6.76	5.86	0.90	0.45	0.45	3.16	0.45	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	11.11	4.36	0.40	1.59	1.19	2.38	0.40	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	0.93	8.36	0.00	0.93	0.00	1.86	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	7.57	9.46	2.65	1.89	1.51	3.78	1.14	1.14	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	5.54	4.24	1.96	0.65	0.33	2.28	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	6.10	6.54	0.44	1.31	0.00	4.36	0.00	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	17.64	10.40	4.98	0.00	0.45	1.81	0.00	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	13.23	5.29	2.65	0.00	0.88	0.88	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	11.97	13.96	1.99	0.66	1.99	1.33	0.00	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	8.43	7.44	0.50	0.50	0.99	1.49	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	4.98	3.06	0.77	0.77	0.77	4.21	0.00	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	20.87	13.61	4.84	0.91	8.17	5.14	0.30	0.60	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	13.26	6.85	4.86	1.99	1.11	4.64	0.66	0.44	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	10.16	2.71	1.36	2.03	0.68	2.71	0.68	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	51.10	15.33	25.55	5.11	0.00	10.22	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	9.15	6.71	0.61	2.44	1.22	5.49	0.61	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	2.83	3.15	2.20	1.57	0.94	5.35	0.00	0.63	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	5.15	3.93	2.72	0.91	1.21	2.42	0.61	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	14.24	5.54	3.16	2.37	0.00	2.37	0.79	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	18.14	9.07	6.80	1.13	0.00	12.47	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	70.81	40.46	5.06	0.00	0.00	30.35	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	70.06	24.47	2.73	0.50	0.75	1.74	0.50	0.75	0.25
Myoblast, donor2	11322-117D8	41.04	20.71	2.11	1.92	0.77	3.26	1.73	0.96	0.19
Myoblast, donor3	11398-118D3	77.86	29.26	3.87	1.18	1.18	1.85	0.00	0.84	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	258.59	44.95	25.25	2.63	10.36	3.06	7.30	0.73	1.90
Natural Killer Cells, donor1	11230-116C6	29.52	10.46	5.23	1.54	26.45	0.31	12.92	0.62	5.54
Natural Killer Cells, donor2	11311-117C6	15.68	8.14	1.81	1.21	30.16	0.90	31.66	1.21	6.33
Natural Killer Cells, donor3	11387-118C1	16.56	5.71	3.31	1.47	50.61	1.66	33.68	0.00	11.41
Neural stem cells, donor1	11275-116H6	73.68	25.77	12.70	9.07	0.00	1.09	0.00	0.00	0.00
Neural stem cells, donor2	11352-117H2	48.14	13.48	9.63	5.78	0.00	7.70	0.00	0.00	0.00
Neurons, donor1	11494-119E9	28.45	6.83	4.55	7.97	10.24	3.41	10.24	0.00	1.14
Neurons, donor2	11574-120E8	21.80	11.45	7.93	7.49	5.72	4.40	1.76	0.22	1.10
Neurons, donor3	11655-122E8	22.20	4.93	6.58	1.64	12.33	1.64	8.22	0.00	2.47
Neutrophils, donor1	11233-116C9	2.78	0.93	0.00	0.93	0.93	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	2.90	0.00	0.00	0.00	0.00	0.00	2.90	0.00	0.00
Neutrophils, donor3	11390-118C4	0.61	0.61	0.00	0.00	0.61	0.00	0.00	0.61	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	53.79	35.86	5.70	3.80	0.36	3.44	0.12	1.42	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	14.65	18.88	3.26	2.60	0.65	1.95	0.33	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	24.07	15.24	4.01	2.81	0.80	1.40	0.80	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	9.77	8.67	3.30	3.58	2.20	1.65	1.51	0.55	0.28
Olfactory epithelial cells, donor2	11934-125I8	16.50	10.13	2.61	2.03	1.45	2.46	1.16	0.43	0.29
Olfactory epithelial cells, donor3	11935-125I9	9.19	6.92	4.20	2.38	1.02	1.14	1.93	0.34	0.11
Olfactory epithelial cells, donor4	11936-126A1	8.86	11.69	1.95	1.56	1.66	2.05	0.78	0.29	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	42.13	21.06	10.83	1.81	0.00	3.01	0.00	1.20	0.00
Osteoblast - differentiated, donor1	11276-116H7	17.65	7.66	6.17	2.55	0.00	4.04	0.00	0.21	0.00
Osteoblast - differentiated, donor2	11353-117H3	5.72	1.14	4.57	2.29	0.00	5.72	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	8.69	6.83	1.86	0.00	0.62	3.72	0.62	0.62	0.00
Osteoblast, donor1	11277-116H8	32.44	14.66	8.40	2.35	3.71	4.69	0.00	0.98	0.00
Osteoblast, donor2	11354-117H4	32.31	11.24	7.73	2.81	1.40	4.21	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	16.17	9.78	5.51	2.31	1.78	6.04	0.00	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	16.26	10.45	1.94	1.26	0.59	1.68	0.42	0.17	0.08
Pericytes, donor1	11491-119E6	7.45	3.67	3.23	1.56	0.56	0.33	0.56	0.33	0.11
Pericytes, donor2	11571-120E5	3.62	3.85	1.81	4.30	0.68	0.91	0.45	0.23	0.23
Pericytes, donor3	11652-122E5	2.64	2.64	0.61	0.41	0.00	0.61	1.22	0.20	0.00
Perineurial Cells, donor1	11499-119F5	11.64	15.71	6.44	2.15	1.70	2.49	1.24	1.24	0.11
Perineurial Cells, donor2	11579-120F4	51.53	22.54	4.23	1.56	1.10	2.48	0.09	0.37	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	22.63	16.57	3.51	2.23	2.55	0.64	2.87	0.00	1.27
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	12.49	10.28	2.69	1.96	6.86	1.22	17.39	0.24	2.94
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	10.87	11.78	1.42	2.07	8.93	0.52	10.22	0.00	1.68
Placental Epithelial Cells, donor1	11278-116H9	8.13	7.17	2.87	0.48	4.78	0.96	0.24	0.72	0.24
Placental Epithelial Cells, donor2	11355-117H5	6.65	7.76	4.44	1.11	0.00	3.33	2.22	1.11	1.11
Placental Epithelial Cells, donor3	11427-118G5	6.68	7.85	4.91	4.52	1.37	1.18	0.59	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	26.58	10.44	3.48	1.90	0.00	2.53	0.00	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	54.03	12.01	1.69	0.56	1.13	2.81	0.00	0.94	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	67.22	23.23	1.44	0.52	8.09	2.87	1.17	1.17	0.91
Preadipocyte - breast, donor2	11328-117E5	37.15	16.21	3.15	1.80	1.13	3.15	0.68	0.90	0.45
Preadipocyte - omental, donor1	11468-119C1	39.21	11.83	2.02	1.17	0.96	3.62	0.53	0.21	0.11
Preadipocyte - omental, donor2	11329-117E6	58.49	27.50	2.62	0.87	0.44	3.49	0.87	0.87	0.00
Preadipocyte - omental, donor3	11403-118D8	28.94	12.75	2.58	2.58	1.43	3.58	1.29	0.43	0.00
Preadipocyte - perirenal, donor1	11469-119C2	27.56	5.91	0.00	1.97	2.95	2.95	2.95	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	26.72	8.91	0.31	0.00	2.46	2.15	0.61	0.92	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	14.17	10.80	2.66	0.18	0.18	1.95	0.18	0.53	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	24.35	12.60	2.55	0.85	1.02	4.60	0.34	0.85	0.17
Preadipocyte - visceral, donor1	11280-116I2	26.73	17.42	2.24	1.12	0.47	1.77	0.19	0.37	0.00
Preadipocyte - visceral, donor2	11357-117H7	22.09	16.57	3.68	1.84	0.00	2.76	0.00	0.92	0.00
Preadipocyte - visceral, donor3	11429-118G7	21.63	13.17	1.88	0.42	0.94	1.36	0.42	0.73	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	72.26	5.58	22.78	4.37	1.36	1.96	0.45	0.15	0.45
Prostate Epithelial Cells, donor2	11331-117E8	2.71	2.03	2.03	0.41	0.41	1.35	0.41	0.00	0.14
Prostate Epithelial Cells, donor3	11404-118D9	0.80	0.67	0.18	0.06	0.67	0.31	0.49	0.00	0.06
Prostate Stromal Cells, donor1	11254-116F3	33.26	14.58	1.59	0.23	0.91	1.48	0.23	0.68	0.11
Prostate Stromal Cells, donor2	11332-117E9	16.14	10.22	1.79	0.36	0.72	2.51	0.00	0.18	0.18
Prostate Stromal Cells, donor3	11405-118E1	12.51	8.45	3.65	1.25	1.25	1.98	0.21	0.52	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	7.66	8.39	10.22	2.92	0.73	1.09	0.36	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	27.72	19.75	16.22	5.48	1.04	1.52	0.76	1.39	0.14
Renal Epithelial Cells, donor1	11517-119H5	7.10	8.62	4.57	0.51	0.00	2.54	1.01	0.00	0.51
Renal Epithelial Cells, donor2	11597-120H4	9.96	17.07	4.98	2.13	1.42	1.42	0.71	1.42	0.00
Renal Epithelial Cells, donor3	11678-122H4	27.21	20.11	17.04	5.19	0.42	2.65	0.11	1.38	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	2.04	4.77	2.72	0.68	0.00	0.68	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	6.60	5.66	5.12	2.29	0.67	1.35	0.27	0.00	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	9.77	10.21	12.88	1.55	0.89	2.00	0.00	0.89	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	2.00	2.00	3.33	2.66	0.67	0.00	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	15.19	8.14	6.16	2.86	1.32	0.66	0.44	0.44	0.22
Renal Mesangial Cells, donor2	11598-120H5	10.66	8.15	8.15	3.13	1.88	1.25	0.00	0.00	1.25
Renal Mesangial Cells, donor3	11679-122H5	6.66	5.55	3.61	2.50	1.39	0.55	0.28	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	12.35	13.96	2.68	1.07	0.00	0.54	0.00	1.07	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	5.06	9.28	5.06	1.27	0.84	0.00	0.00	0.42	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	11.19	11.96	8.29	2.51	0.77	1.35	1.54	0.39	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	17.11	14.78	15.30	5.70	0.52	1.81	0.00	0.78	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	9.10	7.96	8.81	3.13	1.14	1.14	0.28	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	4.12	7.20	3.09	2.06	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	29.36	13.05	7.78	2.76	0.50	2.26	0.50	0.50	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	275.02	29.80	6.41	2.14	3.74	12.96	1.20	1.07	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	24.12	10.72	5.36	2.68	5.36	2.68	3.57	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	80.35	14.31	9.91	0.55	0.55	8.81	0.00	0.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	24.36	9.86	5.80	0.00	0.58	2.32	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	42.39	11.05	7.15	3.25	0.78	1.95	0.26	0.39	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	29.49	10.63	6.55	2.98	1.19	1.79	1.39	0.40	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	70.16	18.29	10.48	3.46	4.35	1.90	1.45	0.67	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	68.10	16.87	14.76	2.85	0.62	3.10	0.87	1.36	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	36.01	13.29	8.27	3.50	1.40	2.10	1.28	0.35	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	59.63	13.41	10.86	2.77	3.47	2.08	1.85	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	22.04	10.41	7.94	2.60	1.10	1.64	0.55	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	45.08	12.71	6.96	2.12	2.12	0.45	1.21	0.91	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	53.76	16.84	8.06	2.33	8.96	2.87	1.43	0.54	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	28.98	11.76	7.89	2.30	1.43	2.73	0.43	0.29	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	39.81	14.92	7.73	2.47	1.40	1.93	1.50	0.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	43.37	12.61	9.96	2.66	3.76	1.99	1.11	0.44	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	24.28	9.37	7.46	1.15	0.76	2.10	0.57	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	33.17	10.99	6.52	2.89	1.58	1.68	1.21	0.47	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	68.21	14.09	13.15	4.13	1.69	1.50	0.94	0.94	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	27.47	10.09	7.83	1.59	0.53	1.86	0.80	0.66	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	30.86	10.51	6.72	2.34	2.34	2.04	0.39	0.39	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	42.58	15.28	11.27	3.25	2.29	1.15	1.34	0.38	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	30.01	11.53	7.37	1.50	0.85	1.60	0.43	0.85	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	33.64	12.61	6.73	1.96	0.84	1.12	1.12	0.00	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	39.65	10.08	5.30	2.22	3.08	2.22	1.54	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	22.61	8.93	9.12	1.09	1.64	1.64	0.36	0.91	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	30.17	11.40	7.24	2.58	1.23	1.72	0.86	0.49	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	44.73	13.57	8.87	4.84	2.69	2.42	1.21	0.67	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	36.32	14.39	9.20	0.94	1.18	1.89	0.71	0.94	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	36.90	13.29	7.14	4.56	0.40	1.98	1.39	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	44.90	14.03	10.99	3.74	4.44	3.04	1.40	0.70	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	25.71	10.37	10.99	2.70	1.87	2.90	0.41	0.41	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	49.77	11.50	7.08	1.55	1.55	0.88	1.99	0.44	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	31.33	11.07	8.36	2.30	2.92	1.46	0.63	0.21	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	29.20	14.94	9.69	1.88	0.81	2.83	0.54	0.54	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	27.59	9.37	5.45	2.21	1.36	2.04	1.19	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	32.00	11.57	6.17	4.05	2.89	2.31	1.35	0.58	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	28.71	13.93	10.32	2.06	1.20	2.75	1.03	0.52	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	25.65	7.41	8.23	3.84	1.65	1.37	0.69	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	45.47	11.66	11.16	3.28	2.96	1.31	1.31	0.16	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	20.28	11.42	8.86	1.53	0.51	2.22	0.68	0.51	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	35.21	11.69	8.73	3.11	0.59	2.37	0.44	0.89	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	27.45	12.26	5.33	4.00	3.20	1.60	1.33	0.80	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	48.25	9.13	8.30	0.97	1.52	1.94	0.97	0.97	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	48.57	15.24	10.00	3.10	1.90	1.67	0.71	0.48	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	34.67	13.70	8.46	2.62	0.20	1.41	0.60	0.20	1.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	39.74	11.87	8.85	1.88	0.94	1.60	0.94	1.13	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	58.34	17.12	7.34	3.84	1.75	3.14	1.75	1.40	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	30.52	10.58	6.65	0.60	4.23	1.81	1.21	1.21	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	28.27	12.12	8.08	1.59	2.94	1.59	0.61	1.22	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	59.68	18.19	9.46	3.20	13.97	4.80	1.31	0.29	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	49.28	10.34	4.26	1.22	12.17	0.61	1.22	2.43	4.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	32.25	10.85	6.93	0.30	2.11	1.81	1.21	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	39.81	13.35	3.85	2.71	2.71	1.58	1.58	0.23	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	25.16	15.28	8.09	2.40	7.49	3.00	4.19	0.90	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	46.17	9.33	9.33	1.30	1.06	2.83	0.47	0.59	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	35.65	9.18	4.27	3.42	2.13	2.35	0.64	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	26.44	7.81	7.21	2.40	1.20	0.60	0.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	3.76	4.51	4.51	1.88	0.38	0.38	0.56	0.00	0.19
Schwann Cells, donor2	11578-120F3	3.40	3.40	0.00	0.00	0.00	6.80	0.00	3.40	0.00
Schwann Cells, donor3	11659-122F3	7.01	9.42	7.67	3.94	1.10	1.53	1.31	0.44	0.44
Sebocyte, donor1	11220-116B5	17.53	12.05	4.38	0.55	0.00	2.19	0.00	1.10	0.00
Sebocyte, donor2	11301-117B5	11.49	11.49	0.92	0.46	0.00	0.92	0.46	0.46	0.00
Sebocyte, donor3	11378-118B1	9.69	9.69	1.86	0.82	0.41	0.62	0.21	0.21	0.41
Sertoli Cells, donor1	11255-116F4	46.38	18.22	3.31	3.31	0.00	6.63	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	22.59	16.95	5.65	0.00	2.82	5.65	5.65	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	26.31	14.60	5.28	1.85	0.88	2.38	0.35	0.18	0.09
Skeletal Muscle Cells, donor2	11358-117H8	10.12	4.34	3.61	0.00	5.78	2.17	0.72	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	28.43	17.56	5.85	4.18	4.18	0.00	0.84	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	50.90	21.52	3.61	1.26	2.20	0.47	2.20	0.79	0.16
Skeletal Muscle Cells, donor5	11455-119A6	48.61	20.36	2.97	1.04	1.49	1.04	1.34	1.19	0.30
Skeletal Muscle Cells, donor6	11459-119B1	26.47	20.47	5.69	0.77	1.39	2.15	1.85	0.92	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	53.68	34.27	6.30	3.02	1.76	2.39	0.88	2.14	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	33.82	23.12	2.71	0.86	1.14	1.71	2.14	1.14	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	36.71	26.19	4.46	1.19	1.49	2.08	1.09	0.89	0.50
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	51.98	21.15	16.43	3.03	0.59	7.25	0.25	0.76	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	23.16	16.65	2.90	2.90	1.45	3.62	2.90	1.45	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	16.51	7.98	3.85	2.48	0.96	2.34	0.28	0.55	0.00
Skin - palm, donor1	10286-104F7	2.69	0.00	0.00	0.00	0.00	0.00	8.06	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	2.16	1.44	1.01	0.29	0.14	1.01	0.00	0.14	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	4.09	1.64	0.82	0.00	0.82	1.64	0.00	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	2.60	3.64	1.17	0.26	0.00	0.26	0.13	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	6.95	5.00	0.97	0.70	0.56	0.42	0.70	0.00	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	3.80	2.67	1.13	0.14	0.14	0.70	0.14	0.28	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	8.03	6.77	1.90	0.42	13.32	0.85	2.75	0.42	0.85
Small Airway Epithelial Cells, donor3	11406-118E2	1.80	2.17	1.05	0.45	0.30	0.45	0.22	0.45	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	10.49	8.02	2.47	0.93	0.00	3.39	0.00	0.93	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	14.45	7.34	2.00	0.44	2.22	1.56	0.44	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	14.11	12.34	1.76	1.76	1.18	2.35	0.00	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	23.65	15.25	1.55	0.00	0.66	1.10	0.22	0.44	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	20.87	6.30	1.58	0.79	1.18	2.36	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	22.40	14.68	0.77	0.00	4.64	0.77	0.77	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	60.05	17.01	3.00	1.00	3.00	0.00	1.00	1.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	23.69	16.90	0.93	0.40	1.06	2.13	0.27	0.53	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	13.52	11.08	3.55	1.77	1.11	1.99	0.22	0.22	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	25.22	12.93	2.82	1.41	0.51	1.79	0.00	0.51	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	27.68	13.02	9.44	2.28	2.60	1.63	0.33	0.33	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	15.06	11.22	5.91	3.25	1.77	2.07	0.89	0.30	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	9.82	8.54	3.56	1.28	1.42	1.14	0.43	0.43	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	5.69	3.42	0.33	0.16	0.33	0.81	0.33	0.00	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	19.18	12.18	1.22	1.52	0.91	0.61	0.61	0.30	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	28.79	18.18	1.52	0.76	2.53	0.25	0.25	0.25	0.76
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	0.00	0.00	6.12	6.12	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	12.40	9.54	1.91	0.48	2.86	2.38	0.95	0.48	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	30.82	16.81	3.24	1.33	1.03	1.33	1.18	0.44	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	22.60	10.33	3.23	1.29	0.65	1.08	0.22	0.43	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	25.71	13.64	3.99	0.94	1.57	1.89	0.31	0.52	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	20.42	9.59	1.24	0.31	1.08	1.86	0.00	0.62	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	19.40	17.25	2.16	1.08	3.23	1.08	0.00	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	22.71	8.37	2.09	0.30	2.09	1.49	0.30	1.20	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	6.15	4.78	1.02	0.00	0.34	1.02	0.34	0.68	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	41.38	20.65	5.26	2.75	0.86	1.41	0.79	0.63	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	6.34	3.42	2.01	1.11	0.20	0.81	0.10	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	27.08	10.24	0.00	0.46	0.91	2.05	1.14	0.46	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	21.74	9.66	0.60	0.00	0.60	1.21	0.00	1.21	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	44.24	24.90	5.03	1.32	0.79	1.85	0.53	0.53	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	7.06	4.39	2.13	0.67	0.40	0.40	0.13	0.67	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	17.03	9.39	2.63	1.38	0.63	1.88	0.75	0.25	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	2.54	5.07	3.04	2.03	0.51	0.76	0.00	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	48.10	20.81	1.51	1.36	1.81	1.66	0.30	0.30	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	21.75	12.00	0.75	1.50	0.75	0.75	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	1.29	1.29	1.29	1.29	0.00	1.29	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	24.18	13.95	1.86	0.47	1.86	3.26	0.47	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	11.61	11.11	2.02	0.00	0.00	0.50	1.01	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	14.10	11.91	1.88	0.63	0.63	1.25	0.31	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	6.19	4.72	0.00	0.59	0.00	0.29	0.00	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	21.83	15.66	3.50	1.08	0.17	1.92	0.08	0.33	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	18.22	14.95	0.93	1.87	0.93	1.40	0.47	0.93	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	20.44	14.54	3.60	0.86	0.72	2.16	0.14	0.29	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	16.83	17.85	2.80	1.78	2.04	1.02	0.76	1.02	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	11.85	10.34	3.01	1.32	1.32	1.32	0.38	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	25.01	14.53	7.13	2.10	0.28	1.12	0.14	1.54	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	20.86	13.32	6.87	2.43	0.42	1.59	0.08	1.01	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	0.00	2.86	0.95	1.43	0.95	0.00	1.43	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	19.57	12.72	2.94	1.96	0.98	1.22	0.24	0.49	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	5.30	2.65	0.66	0.66	0.22	0.66	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	0.59	2.05	0.88	0.88	0.88	0.88	0.00	0.00	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	11.08	8.36	4.08	1.94	0.58	1.75	0.00	0.39	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	9.26	7.93	1.59	0.00	0.26	1.32	0.26	0.26	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	30.13	8.93	1.86	0.37	0.37	1.12	0.37	0.37	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	10.78	7.91	3.95	0.00	0.72	2.16	0.00	1.08	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	3.69	6.25	1.99	0.28	0.57	0.28	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	7.48	8.67	1.97	1.58	0.00	1.97	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	32.25	10.16	1.02	1.78	0.25	1.52	0.25	0.51	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	25.96	12.38	2.00	2.00	0.40	1.20	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	13.79	4.60	0.42	1.25	1.67	1.67	0.42	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	13.29	9.63	2.75	1.38	3.21	2.75	0.46	0.00	0.46
Synoviocyte, donor1	11291-117A4	13.47	9.26	3.87	4.38	1.51	3.87	0.50	0.67	0.34
Synoviocyte, donor2	11368-117I9	32.35	27.99	0.84	1.01	3.18	2.51	1.17	1.01	0.34
Synoviocyte, donor3	11440-118H9	28.60	19.66	0.89	1.79	2.01	2.90	1.34	0.89	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	12.51	10.36	3.22	0.36	1.07	1.43	0.36	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	13.87	1.98	0.00	0.00	0.00	1.98	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	10.19	8.10	2.08	1.39	0.23	0.93	0.23	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	1.58	2.65	0.36	0.14	0.07	0.43	0.22	0.07	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	4.25	4.64	1.55	0.00	1.16	0.77	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	1.72	1.15	0.00	0.00	2.29	0.00	1.15	0.57	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	292.31	31.74	10.46	2.46	1.60	13.78	0.62	0.49	0.49
Urethra, donor2	10319-105A4	1.80	1.80	1.80	1.80	1.80	0.00	1.80	3.60	0.00
Urothelial Cells, donor1	11520-119H8	2.39	0.53	0.53	0.27	1.06	0.80	0.53	0.00	0.27
Urothelial Cells, donor2	11600-120H7	1.20	0.40	0.40	0.00	0.40	0.80	0.00	0.00	0.80
Urothelial Cells, donor3	11681-122H7	0.92	0.69	0.69	0.00	2.52	0.00	1.83	0.00	0.46
Urothelial cells, donor0	11216-116B1	4.46	4.01	4.68	1.56	0.22	1.78	0.67	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	20.47	12.46	5.34	0.00	9.79	0.00	6.23	0.00	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	17.16	18.58	4.29	4.29	7.15	2.86	4.29	0.00	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	6.85	5.48	2.05	4.79	14.37	1.37	9.58	0.68	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	19.28	16.87	5.85	2.75	21.35	0.34	12.74	1.03	2.75
Whole blood (ribopure), donor090325, donation2	12177-128I8	31.96	19.75	4.65	1.74	16.27	1.16	12.78	0.00	4.07
Whole blood (ribopure), donor090612, donation1	12182-129A4	24.99	12.49	6.25	0.00	2.08	1.04	6.25	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	16.52	7.34	7.34	0.92	6.42	0.92	3.67	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	19.17	13.69	7.30	2.74	11.87	0.91	15.52	1.83	2.74
Wilms' tumor cell line:G-401	10809-111A8	36.02	14.93	25.04	8.39	2.34	0.86	1.85	0.99	0.25
Wilms' tumor cell line:HFWT	10597-108E3	2.64	7.04	1.76	0.88	0.00	1.76	0.00	0.00	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	13.13	6.14	0.28	0.84	0.84	0.84	1.12	0.28	0.00
achilles tendon, donor2	10292-104G4	18.60	6.20	0.00	0.00	0.00	0.00	6.20	2.07	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	91.53	56.86	26.01	8.16	1.53	1.27	0.00	4.59	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	54.79	35.29	14.86	5.57	0.70	0.46	0.93	2.55	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	2.18	5.17	4.35	11.97	1.63	0.54	0.54	0.27	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	34.01	20.80	7.87	1.69	0.28	1.12	0.28	1.97	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	49.06	30.24	12.69	4.23	5.08	1.69	1.27	1.27	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	10.34	6.53	3.81	0.82	0.27	0.54	0.27	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	34.37	24.68	10.13	1.76	1.76	2.20	0.00	1.76	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	34.95	47.37	5.44	3.11	3.88	0.78	2.33	2.72	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	19.50	19.50	15.60	7.80	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	14.50	14.50	9.32	2.07	0.26	0.52	0.52	0.78	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	22.80	24.26	12.57	2.34	0.88	0.88	0.00	1.17	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	10.22	19.98	3.72	0.46	0.46	1.39	0.00	1.39	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	37.42	16.86	9.46	2.06	0.41	2.47	0.00	0.82	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	1.23	2.46	6.14	1.84	0.00	0.31	0.00	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	13.65	19.20	6.40	2.13	0.43	0.43	0.85	0.85	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	13.34	16.38	7.58	4.55	0.00	0.61	0.00	0.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	20.94	15.16	10.11	1.93	0.48	0.24	0.48	2.17	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	30.29	23.16	14.03	3.34	0.00	0.89	0.22	2.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	3.67	4.34	3.67	3.34	0.00	0.00	0.00	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	5.57	5.57	7.43	5.57	1.86	0.00	5.57	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	2.26	6.40	5.27	1.88	0.00	0.38	0.00	0.38	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	23.55	20.93	11.78	6.54	2.18	0.00	0.44	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	13.12	5.62	1.87	3.75	1.87	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	51.57	33.91	8.48	2.35	5.42	2.12	3.53	0.71	1.41
adipose tissue, adult, pool1	10010-101C1	87.95	30.71	3.57	0.16	1.55	5.12	0.47	2.02	0.16
adipose, donor1	10184-103D4	33.43	8.80	69.20	24.04	5.28	5.28	4.10	0.00	1.76
adipose, donor2	10185-103D5	14.60	4.46	10.54	11.76	12.57	0.81	2.43	0.41	1.22
adipose, donor3	10186-103D6	14.16	7.62	23.42	13.34	9.26	1.09	4.63	0.27	0.54
adipose, donor4	10187-103D7	27.74	11.27	40.74	12.13	5.20	0.87	2.60	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	12.15	21.31	32.04	79.07	4.58	1.42	3.79	0.63	0.47
adrenal gland, adult, pool1	10081-102A9	18.19	14.55	3.64	3.64	3.64	0.00	3.64	0.00	7.28
adult T-cell leukemia cell line:ATN-1	10421-106C7	32.95	28.68	6.00	3.20	1.47	1.73	0.53	1.20	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	22.15	10.36	5.36	1.79	1.07	0.71	0.71	0.00	0.36
amniotic membrane cells, donor1	12235-129G3	1.85	2.78	2.55	1.62	2.55	2.78	0.23	0.23	0.46
amniotic membrane cells, donor2	12236-129G4	4.06	7.10	10.14	6.42	3.04	1.69	0.00	0.68	0.00
amniotic membrane cells, donor3	12237-129G5	5.01	4.71	3.54	3.24	1.47	2.95	0.00	0.29	0.00
amygdala - adult, donor10196	10167-103B5	13.04	7.11	1.19	1.19	0.00	0.00	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	20.28	14.19	3.65	9.12	1.01	1.62	2.03	0.00	0.41
amygdala, newborn, donor10223	10360-105E9	8.07	3.87	1.61	2.26	1.94	1.94	1.94	0.32	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	13.62	7.00	5.09	2.42	0.89	1.02	0.13	0.38	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	28.68	13.46	6.84	2.65	6.40	0.22	1.76	1.54	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	1.34	1.67	2.67	3.34	3.01	0.00	0.67	0.33	0.33
aorta, adult, pool1	10052-101G7	7.65	9.41	2.94	5.10	4.71	2.75	3.33	0.39	0.39
appendix, adult	10189-103D9	28.72	13.20	4.66	2.72	3.49	1.55	1.55	0.39	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	70.51	31.30	52.62	30.27	1.72	1.72	2.41	1.38	1.03
artery, adult	10190-103E1	16.30	21.74	2.72	4.08	0.00	0.00	4.08	5.43	1.36
astrocytoma cell line:TM-31	10425-106D2	19.99	8.98	6.23	3.77	0.58	0.87	0.58	0.43	0.29
b cell line:RPMI1788	10427-106D4	23.35	17.25	7.88	6.39	0.15	0.45	0.45	1.04	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	31.07	16.65	3.33	0.83	1.94	4.72	0.00	1.39	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	11.81	6.15	2.38	0.40	0.00	0.79	0.10	0.10	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	0.33	0.33	0.50	0.50	0.17	0.00	0.00	0.00	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	7.83	7.27	2.80	0.00	2.24	0.00	1.12	0.56	0.00
bladder, adult, pool1	10011-101C2	21.08	12.93	3.37	2.39	2.06	2.93	1.85	0.76	0.22
blood, adult, pool1	10053-101G8	8.86	11.07	2.21	0.00	6.64	2.21	6.64	0.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	23.98	23.12	3.43	2.57	0.00	0.86	0.00	0.86	0.00
bone marrow, adult	10192-103E3	66.13	20.92	4.05	2.70	2.70	1.35	2.02	0.00	0.67
brain, adult, donor1	10084-102B3	47.15	7.18	2.05	3.08	3.08	1.03	2.05	0.00	0.00
brain, adult, pool1	10012-101C3	24.72	9.13	3.67	6.12	1.78	2.56	0.33	1.00	0.00
brain, fetal, pool1	10085-102B4	8.01	5.34	5.34	2.67	29.39	0.00	10.69	0.00	5.34
breast carcinoma cell line:MCF7	10482-107A5	6.94	4.63	6.94	0.99	0.00	0.66	0.66	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	0.00	0.00	0.25	0.25	0.12	0.25	0.12	0.00	0.00
breast, adult, donor1	10080-102A8	42.93	7.58	2.53	1.89	3.16	1.89	1.89	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	0.00	0.00	0.25	0.38	0.38	0.00	0.64	0.00	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	0.31	1.24	0.93	1.24	0.00	0.00	0.62	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	5.99	10.59	7.37	6.22	0.46	1.61	0.46	2.07	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	22.27	13.80	11.38	6.29	1.69	0.48	1.21	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	82.28	24.45	9.40	4.70	6.58	1.88	6.11	0.47	0.94
carcinoid cell line:NCI-H727	10735-110B6	11.92	7.98	13.02	5.36	0.11	1.53	0.44	1.20	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	10.77	3.80	8.87	7.92	0.95	0.00	1.58	0.00	0.95
carcinosarcoma cell line:JHUCS-1	10642-109A3	37.26	17.30	13.31	4.79	4.26	1.06	5.32	1.06	0.80
caudate nucleus - adult, donor10196	10177-103C6	29.93	10.36	2.30	9.21	0.00	0.00	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	36.48	17.74	2.84	8.87	1.84	1.84	2.84	1.34	0.17
caudate nucleus, adult, donor10258	10379-105H1	30.57	9.17	1.53	6.11	3.06	0.00	5.35	0.76	0.76
caudate nucleus, newborn, donor10223	10354-105E3	17.58	6.96	4.03	3.66	5.49	1.10	3.30	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	11.65	5.83	2.91	0.00	2.91	2.91	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	18.36	5.55	5.55	6.83	0.64	2.35	0.64	0.43	0.21
cerebellum, adult, pool1	10083-102B2	8.97	2.07	2.76	2.07	11.04	0.69	2.41	0.34	3.10
cerebellum, newborn, donor10223	10357-105E6	15.78	8.30	6.64	6.64	2.49	3.32	3.32	0.00	0.83
cerebral meninges, adult	10188-103D8	15.38	5.80	2.52	5.55	1.26	1.01	0.50	0.25	0.00
cerebrospinal fluid, donor2	10294-104G6	16.81	6.58	2.92	5.85	2.19	0.00	1.46	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	21.42	14.95	1.73	0.58	2.01	0.29	0.86	0.58	0.43
cervical cancer cell line:ME-180	10553-107I4	0.99	0.99	1.16	0.33	2.49	0.50	1.16	0.00	0.66
cervix, adult, pool1	10013-101C4	11.13	7.66	2.31	2.52	3.57	2.31	1.36	0.21	0.84
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	111.47	28.84	5.16	2.37	11.43	3.20	4.32	0.98	1.53
chondrosarcoma cell line:SW 1353	10700-109G7	5.23	2.61	2.61	3.92	1.31	5.23	1.31	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	17.40	14.04	15.91	8.70	1.24	0.50	0.25	0.62	0.00
choriocarcinoma cell line:SCH	10785-110H2	38.32	17.25	16.63	13.55	1.23	0.25	1.23	0.99	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	1.90	0.95	4.98	4.27	0.24	0.00	0.00	0.47	0.24
chorionic membrane cells, donor1	12238-129G6	1.99	2.56	1.42	0.85	7.12	1.42	1.42	0.00	0.28
chorionic membrane cells, donor2	12239-129G7	14.52	10.54	6.16	3.18	0.70	1.99	0.00	0.40	0.10
chorionic membrane cells, donor3	12240-129G8	1.10	2.75	2.75	2.75	1.65	0.55	0.55	0.55	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	31.30	9.09	9.09	0.00	0.00	0.00	1.01	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	16.90	25.74	6.53	0.77	1.73	0.77	2.11	0.19	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	14.36	19.01	3.38	0.84	1.48	1.06	0.21	0.21	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	2.31	1.28	3.34	3.85	0.00	0.26	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	2.42	2.18	5.81	4.11	0.24	0.00	0.00	0.24	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	2.24	2.44	5.90	3.26	0.20	0.00	0.00	0.20	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	10.60	3.24	4.42	3.83	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	30.23	31.28	6.26	1.30	0.00	2.09	0.52	1.04	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	26.52	34.06	13.71	10.97	2.06	1.14	1.37	2.51	0.23
clear cell carcinoma cell line:TEN	10636-108I6	7.98	6.42	7.63	3.30	1.39	1.39	0.87	0.69	0.00
colon carcinoma cell line:CACO-2	10513-107D9	246.19	15.01	56.38	7.87	2.01	4.03	0.55	0.55	0.37
colon carcinoma cell line:COLO-320	10420-106C6	24.71	20.14	26.99	10.26	0.38	1.52	0.38	0.38	0.76
colon, adult, donor1	10082-102B1	77.35	29.75	7.14	0.00	21.42	7.14	5.95	3.57	5.95
colon, adult, pool1	10014-101C5	135.01	24.32	18.92	1.18	5.29	7.64	1.18	1.18	0.12
colon, fetal, donor1	10070-101I7	94.55	30.28	17.30	8.03	7.42	3.71	1.24	1.24	0.00
common myeloid progenitor CMP, donor1	12130-128D6	4.58	9.17	13.75	0.00	4.58	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	25.04	0.00	25.04	0.00	50.07	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	102.41	26.35	8.07	0.85	7.65	2.55	1.27	0.00	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	123.46	32.60	9.66	1.21	2.87	2.87	1.81	1.36	0.60
cord blood derived cell line:COBL-a untreated	10449-106F8	137.20	43.15	12.41	1.83	2.54	2.12	0.85	1.83	0.42
corpus callosum, adult, pool1	10042-101F6	25.43	14.70	6.74	13.82	1.99	5.53	1.33	1.77	0.11
cruciate ligament, donor2	10295-104G7	22.69	11.35	0.81	1.62	6.48	1.62	2.43	0.00	2.43
diaphragm, fetal, donor1	10069-101I6	22.47	18.46	4.01	1.61	8.03	2.41	0.80	4.01	4.01
diencephalon, adult	10193-103E4	14.88	8.88	5.52	4.56	2.16	2.64	1.68	0.24	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	30.08	31.23	11.94	0.92	0.46	0.69	1.84	1.84	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	8.98	6.41	2.31	1.03	0.26	0.26	0.26	0.51	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	63.07	13.96	7.70	2.65	0.72	0.96	0.00	0.00	0.00
ductus deferens, adult	10196-103E7	18.44	22.43	5.98	3.49	0.50	1.00	1.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	24.48	18.72	10.08	4.32	17.28	1.44	10.08	1.44	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	32.37	13.24	22.81	2.21	7.36	1.47	6.62	0.00	0.74
dura mater, adult, donor1	10041-101F5	33.86	26.01	1.24	1.40	1.73	3.06	0.66	1.16	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	25.98	7.33	15.77	2.66	9.77	1.33	1.78	0.00	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	39.55	16.19	20.49	5.30	3.01	1.72	0.72	0.29	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	4.32	7.40	1.85	3.08	0.00	0.62	0.62	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	4.84	6.66	1.51	1.82	1.51	0.61	0.91	0.30	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	5.87	6.48	0.62	1.23	0.31	0.31	0.00	0.00	0.31
embryonic pancreas cell line:2C6	10603-108E9	1.31	0.00	1.31	0.00	0.00	1.31	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	24.47	3.69	3.02	2.35	2.35	0.00	0.34	0.34	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	19.39	18.85	6.52	9.97	1.09	4.35	1.63	1.45	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	1.61	2.25	8.04	6.59	0.16	0.80	0.16	0.16	0.00
epidermoid carcinoma cell line:A431	10426-106D3	0.89	0.44	0.11	0.22	0.56	0.11	0.00	0.00	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	0.11	0.22	1.98	1.65	0.33	0.22	0.11	0.00	0.00
epididymis, adult	10197-103E8	9.21	8.79	4.81	4.60	2.30	2.51	0.21	0.84	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	5.85	4.44	3.55	6.39	1.06	1.42	0.18	0.00	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	4.72	2.75	3.54	0.79	0.39	0.00	0.39	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	73.26	35.91	7.47	1.70	0.79	1.83	1.44	0.92	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	68.21	33.95	6.79	1.48	0.49	2.76	0.59	1.28	0.30
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	75.28	37.08	6.61	1.46	0.56	1.23	0.56	1.01	0.22
esophagus, adult, pool1	10015-101C6	21.45	10.94	1.59	1.38	2.34	2.02	0.53	0.53	0.42
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	12.90	2.63	11.90	9.14	1.50	1.25	1.50	0.13	0.25
eye - muscle inferior rectus, donor1	10272-104E2	24.15	26.56	4.83	2.41	0.00	7.24	0.00	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	46.29	25.25	4.21	2.10	2.10	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	11.91	26.79	2.98	2.98	0.00	2.98	4.46	4.46	1.49
eye - muscle superior, donor2	10297-104G9	28.66	18.34	2.29	3.44	1.15	1.15	3.44	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	8.74	7.29	0.00	2.91	1.46	0.00	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	22.63	13.22	5.34	7.12	8.39	4.58	4.32	0.76	1.53
fibrosarcoma cell line:HT-1080	10758-110E2	6.67	4.49	3.33	2.44	0.64	0.90	0.77	0.64	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	12.58	9.02	2.85	1.42	0.95	0.47	0.24	0.24	0.00
frontal lobe, adult, pool1	10040-101F4	25.43	8.54	2.91	6.38	1.03	1.69	0.94	0.66	0.38
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	20.72	6.91	5.10	0.60	1.50	0.60	0.60	0.00	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	10.61	11.61	5.49	3.93	0.55	0.55	0.00	1.01	0.09
gall bladder, adult	10198-103E9	26.56	11.35	6.52	2.90	4.83	2.66	2.41	0.24	0.72
gamma delta positive T cells, donor1	11937-126A2	77.31	41.87	9.13	3.76	168.04	1.07	18.25	0.54	12.88
gamma delta positive T cells, donor2	11938-126A3	48.93	23.90	5.60	2.99	147.90	0.37	22.41	0.37	12.33
gastric adenocarcinoma cell line:MKN1	10614-108G2	63.15	9.72	2.11	0.42	1.90	0.63	0.42	0.42	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	17.02	7.74	6.00	0.58	0.39	0.19	0.39	0.39	0.19
gastric cancer cell line:AZ521	10549-107H9	12.62	15.41	30.00	25.25	0.49	0.49	0.82	0.98	0.16
gastric cancer cell line:GSS	10560-108A2	10.98	8.24	10.07	10.98	1.83	1.83	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	69.45	7.54	21.47	6.40	2.51	0.91	2.74	0.23	0.91
giant cell carcinoma cell line:LU65	10487-107B1	16.64	7.46	0.23	0.00	0.69	0.23	0.11	0.11	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	17.91	12.18	3.22	1.54	0.56	0.28	0.00	0.42	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	0.75	0.25	0.50	0.50	0.50	0.25	0.50	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	12.14	9.18	3.80	3.06	0.42	2.01	0.00	0.32	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	11.94	8.85	4.07	2.53	0.70	1.83	0.28	1.12	0.14
glioblastoma cell line:T98G	10485-107A8	12.58	11.37	4.30	3.64	0.55	0.55	0.33	0.66	0.11
glioma cell line:GI-1	10413-106B8	11.13	8.20	7.32	2.34	0.00	2.05	0.00	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	18.22	12.39	5.10	8.75	3.64	0.73	1.46	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	21.72	16.60	8.79	19.28	0.73	5.86	1.46	1.22	0.24
globus pallidus, adult, donor10258	10367-105F7	16.43	13.69	2.74	13.69	4.11	0.00	0.00	1.37	1.37
globus pallidus, newborn, donor10223	10364-105F4	12.79	4.26	2.66	4.26	4.80	0.53	1.60	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	7.34	14.68	2.45	2.45	2.45	0.00	4.89	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	54.64	54.64	21.86	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	41.81	31.36	10.45	0.00	20.91	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	20.80	13.44	3.84	1.92	1.92	2.56	0.00	0.96	0.00
hIPS +CCl2, biol_rep1	14383-156B9	45.91	14.23	33.52	6.89	0.46	0.92	0.92	1.38	0.46
hIPS +CCl2, biol_rep2	14384-156C1	37.95	15.55	30.18	5.03	0.46	0.91	1.83	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	36.07	17.39	34.14	6.44	0.64	1.29	2.58	0.64	0.00
hIPS, biol_rep1	14380-156B6	41.68	28.75	37.37	1.44	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	43.21	18.52	21.26	4.12	2.74	0.69	3.43	1.37	0.00
hIPS, biol_rep3	14382-156B8	15.45	11.03	2.21	1.10	1.10	1.10	1.10	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	32.76	26.44	9.77	3.16	1.15	0.86	1.44	0.29	0.00
heart - mitral valve, adult	10205-103F7	20.33	11.06	2.09	2.09	2.69	4.48	0.30	0.00	0.00
heart - pulmonic valve, adult	10206-103F8	89.42	23.01	6.80	5.23	1.57	3.66	1.31	0.78	0.52
heart - tricuspid valve, adult	10207-103F9	11.66	14.15	1.67	2.50	4.16	4.16	2.50	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	85.70	24.08	6.12	6.12	3.06	2.65	1.84	1.43	0.20
heart, adult, diseased, donor1	10051-101G6	215.05	45.14	3.83	4.68	1.70	5.11	3.41	3.83	0.00
heart, adult, pool1	10016-101C7	156.38	34.73	3.91	2.30	1.84	3.45	0.46	2.07	0.00
heart, fetal, pool1	10046-101G1	124.35	24.85	13.86	5.54	2.98	2.98	0.92	1.75	0.31
hepatic mesenchymal tumor cell line:LI90	10778-110G4	2.47	4.01	1.23	1.85	2.47	0.93	1.54	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	1.19	3.57	10.70	8.32	0.00	0.00	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	40.22	10.72	44.86	10.28	0.44	1.77	0.88	0.22	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	45.64	12.74	50.13	10.56	0.61	3.16	0.49	0.36	0.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	50.53	14.15	46.89	12.23	0.30	2.93	0.40	0.61	0.20
hepatoma cell line:Li-7	10484-107A7	78.52	11.34	3.45	0.67	0.89	0.22	0.56	0.22	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	46.13	20.10	11.46	3.12	0.70	0.40	0.50	0.90	0.20
hippocampus - adult, donor10196	10169-103B7	8.52	7.57	2.84	8.52	1.89	0.95	2.84	1.89	0.00
hippocampus, adult, donor10252	10153-102I9	20.00	12.65	6.53	13.06	0.61	2.45	1.43	0.61	0.00
hippocampus, adult, donor10258	10374-105G5	11.45	6.47	2.49	1.00	0.50	0.00	1.49	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	11.28	3.88	0.70	2.11	4.93	0.70	2.82	0.35	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	71.41	29.91	102.54	25.02	5.49	3.05	4.88	1.83	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	34.36	14.92	45.75	15.71	5.50	1.57	2.36	0.59	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	42.65	16.25	50.27	16.00	5.59	1.52	2.29	1.02	1.27
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	11.84	3.95	12.41	12.41	6.20	0.00	3.95	0.00	3.38
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	8.52	2.84	17.56	12.14	3.87	2.07	3.61	0.26	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	11.77	6.07	14.43	13.29	8.35	1.14	3.04	0.00	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	18.69	4.67	16.64	8.47	8.17	1.17	2.34	0.29	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	14.43	5.82	14.86	7.97	4.09	1.08	1.29	0.22	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	18.35	6.67	15.85	5.00	10.43	1.25	5.42	0.00	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	17.05	9.00	34.57	11.84	8.76	2.84	0.95	0.00	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	14.79	5.14	23.63	12.70	10.93	1.61	1.45	0.16	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	21.55	6.73	18.85	6.06	13.47	1.35	2.02	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	48.67	14.24	41.00	14.71	2.97	1.72	2.35	0.94	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	51.09	17.69	50.11	10.81	3.93	2.95	0.98	1.47	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	126.55	23.56	87.28	22.69	8.73	1.75	2.62	0.87	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	16.23	4.77	20.05	12.03	4.77	0.57	1.91	0.00	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	16.57	3.92	15.70	8.72	4.36	0.44	0.87	0.44	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	25.49	3.00	32.48	14.49	5.00	1.50	4.00	0.00	1.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	13.75	5.65	13.00	12.43	4.33	0.94	3.96	0.19	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	19.55	5.00	13.64	10.91	5.00	0.91	3.18	0.45	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	15.04	7.83	12.22	13.78	8.46	0.63	2.82	0.31	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	15.68	6.37	24.33	9.63	6.21	1.96	3.92	0.16	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	16.26	6.10	25.55	10.74	2.32	0.58	2.32	0.29	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	18.23	5.98	20.63	10.76	5.38	1.20	3.29	0.60	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	52.65	17.92	55.05	15.15	4.99	1.85	2.03	1.29	0.74
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	47.64	12.55	46.50	12.27	4.28	1.71	0.57	0.00	0.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	89.83	20.82	76.35	14.70	6.94	1.63	4.08	0.82	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	32.04	4.93	33.80	13.73	1.76	3.87	1.76	1.06	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	22.49	8.87	25.97	11.40	4.43	1.27	2.22	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	29.05	8.17	34.50	15.43	2.12	1.51	2.42	0.61	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	18.10	5.69	16.55	8.79	4.14	0.00	2.59	0.00	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	22.58	8.63	21.25	6.64	4.65	0.66	2.66	1.33	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	14.88	5.13	13.08	11.03	4.87	1.28	0.77	0.51	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	15.08	6.14	17.64	6.39	2.05	0.77	1.79	0.26	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	7.57	6.82	15.90	7.57	6.06	0.00	0.76	1.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	12.77	7.73	17.81	6.72	5.04	0.34	2.69	0.67	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	49.03	15.21	47.34	14.73	3.14	2.66	2.66	0.97	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	64.62	19.16	71.75	17.38	2.67	2.23	4.46	1.34	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	58.54	17.07	55.12	16.59	8.78	3.90	5.37	0.49	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	21.70	4.89	25.98	11.61	2.44	1.53	2.14	0.31	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	175.68	19.52	185.43	45.55	6.51	6.51	3.25	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	39.38	4.30	34.09	16.55	8.94	2.98	5.30	0.00	1.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	13.68	5.47	16.97	12.04	3.83	0.00	4.93	0.55	2.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	16.28	6.15	13.03	13.75	3.98	1.45	4.34	0.36	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	21.71	3.91	15.30	9.25	4.98	0.71	6.05	0.36	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	14.32	0.00	20.29	3.58	2.39	1.19	2.39	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	11.38	5.96	28.98	14.36	1.76	1.63	0.81	0.27	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	8.62	5.39	21.28	8.89	5.12	0.27	4.31	0.27	0.00
immature langerhans cells, donor1	11904-125F5	0.24	0.00	0.24	0.00	0.00	0.00	0.00	0.00	0.00
immature langerhans cells, donor2	11905-125F6	1.58	0.79	0.00	0.00	3.17	0.00	0.79	0.00	0.79
insula, adult, pool1	10039-101F3	26.12	7.57	2.93	8.99	1.89	1.42	1.04	0.76	0.76
keratoacanthoma cell line:HKA-1	10791-110H8	0.98	0.33	0.33	0.00	3.58	0.00	2.60	0.00	0.33
kidney, adult, pool1	10017-101C8	179.43	44.16	32.44	10.91	0.40	7.21	0.30	2.10	0.10
kidney, fetal, pool1	10045-101F9	172.31	29.78	33.95	10.75	2.48	3.47	1.77	0.85	0.42
large cell lung carcinoma cell line:IA-LM	10509-107D5	35.51	10.37	5.54	4.83	0.43	0.14	0.57	0.28	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	20.18	13.13	3.32	1.94	1.38	1.38	0.55	0.00	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	1.83	1.10	0.92	0.55	2.02	0.37	2.02	0.00	0.18
left atrium, adult, donor1	10079-102A7	63.20	19.61	4.90	4.90	1.09	1.09	0.00	0.54	0.00
left ventricle, adult, donor1	10078-102A6	183.55	41.46	3.54	1.01	2.02	2.53	0.51	2.53	0.51
leiomyoblastoma cell line:G-402	10721-110A1	65.67	16.42	4.92	1.64	5.20	2.19	1.09	0.00	0.27
leiomyoma cell line:10964C	10569-108B2	14.37	9.70	1.44	0.00	1.44	1.44	0.72	0.36	0.36
leiomyoma cell line:15242A	10570-108B3	11.41	4.89	0.00	0.54	0.54	0.54	1.09	1.09	0.00
leiomyoma cell line:15425	10571-108B4	6.31	7.28	1.94	0.24	0.24	0.24	0.24	0.24	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	57.14	12.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	7.32	3.14	3.14	2.09	1.05	2.09	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	7.32	4.72	3.42	0.35	1.42	0.83	0.71	0.35	0.12
liposarcoma cell line:KMLS-1	10782-110G8	12.03	9.22	5.62	1.41	1.56	1.41	1.09	0.47	0.00
liposarcoma cell line:SW 872	10726-110A6	18.40	9.99	5.60	4.63	1.46	1.10	0.85	0.49	0.37
liver, adult, pool1	10018-101C9	1117.57	60.94	6.32	0.81	2.59	11.51	0.97	0.97	0.32
liver, fetal, pool1	10086-102B5	125.11	22.58	12.23	0.94	7.53	2.82	0.94	0.94	3.76
locus coeruleus - adult, donor10196	10182-103D2	13.42	11.37	3.35	11.08	0.44	1.75	0.44	0.44	0.00
locus coeruleus, adult, donor10252	10165-103B3	17.72	10.52	9.04	11.44	1.85	2.58	1.85	0.18	0.18
locus coeruleus, adult, donor10258	10375-105G6	14.67	8.46	2.82	10.44	6.21	2.82	2.82	0.85	0.56
locus coeruleus, newborn, donor10223	10362-105F2	34.49	9.67	4.21	2.10	0.84	1.26	0.00	0.84	0.00
lung adenocarcinoma cell line:A549	10499-107C4	15.50	11.49	4.84	3.32	0.69	0.14	0.83	0.69	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	5.52	5.52	2.07	2.07	0.00	0.69	0.00	1.38	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	0.00	0.00	0.00	0.13	0.00	0.00	0.00	0.00	0.00
lung, adult, pool1	10019-101D1	22.44	12.29	3.54	2.01	1.06	2.36	0.83	0.24	0.24
lung, fetal, donor1	10068-101I5	30.82	12.56	7.71	2.85	0.29	1.14	0.57	0.00	0.29
lung, right lower lobe, adult, donor1	10075-102A3	13.75	10.08	5.50	3.21	4.58	2.29	1.37	1.37	1.83
lymph node, adult, donor1	10077-102A5	13.25	9.94	2.84	0.95	5.21	1.42	2.37	0.95	0.47
lymphangiectasia cell line:DS-1	10727-110A7	12.71	8.33	3.07	3.29	1.53	0.00	1.53	0.66	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	59.01	34.41	8.00	2.26	0.45	0.91	0.15	1.96	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	0.85	0.85	0.85	0.00	0.00	0.00	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	150.07	51.50	3.11	2.22	0.89	8.44	0.89	3.55	0.44
mature adipocyte, donor2	12232-129F9	235.75	51.88	1.66	1.66	3.32	3.94	0.21	3.74	0.00
mature adipocyte, donor3	12233-129G1	195.58	54.29	4.03	1.90	2.37	6.64	0.24	2.13	0.24
mature adipocyte, donor4	12234-129G2	234.00	66.33	1.32	1.05	1.58	4.74	0.53	3.69	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	12.15	7.62	12.15	6.43	1.19	2.62	0.24	0.24	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	10.15	9.02	2.26	4.51	0.00	0.00	3.38	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	18.39	10.85	4.41	6.07	0.92	1.66	0.55	0.92	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	12.07	7.94	2.54	1.27	0.95	0.64	2.22	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	21.32	3.84	4.69	2.56	0.00	3.41	2.99	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	16.37	7.26	3.04	7.93	0.00	1.52	1.18	0.34	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	18.04	11.67	7.00	7.64	0.21	2.33	1.06	0.21	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	5.78	3.85	0.00	1.93	3.85	0.00	3.85	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	71.77	0.00	0.00	14.35	0.00	14.35	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	7.54	2.51	2.15	2.51	2.15	0.00	1.79	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	17.52	17.52	3.89	9.09	0.00	1.95	1.30	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	14.86	12.07	7.89	13.78	0.15	4.02	0.62	0.93	0.31
medulla oblongata, adult, pool1	10038-101F2	23.51	15.10	4.90	13.47	0.65	3.02	0.65	0.41	0.08
medulla oblongata, newborn, donor10223	10361-105F1	14.58	7.29	3.82	6.25	1.39	1.39	3.47	0.69	0.35
medulloblastoma cell line:D283 Med	10838-111E1	12.84	8.86	12.62	4.43	1.33	1.99	4.21	0.44	0.66
medulloblastoma cell line:ONS-76	10759-110E3	0.86	1.71	2.45	1.59	0.73	0.98	0.61	0.00	0.24
melanoma cell line:COLO 679	10514-107E1	5.75	4.60	6.47	2.44	0.29	0.29	0.00	0.43	0.29
melanoma cell line:G-361	10465-106H6	3.26	4.07	2.99	2.99	0.00	0.54	1.36	0.27	0.00
meningioma cell line:HKBMM	10691-109F7	17.73	13.75	2.17	0.72	2.71	0.72	1.81	0.54	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	45.82	22.91	20.27	6.17	1.76	3.52	1.76	0.88	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	29.81	12.96	29.55	11.41	7.78	2.33	2.33	0.52	1.81
mesenchymal precursor cell - adipose, donor1	11747-123G1	59.23	27.77	2.92	0.92	1.53	2.92	0.77	1.38	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	31.27	10.73	1.64	0.36	0.55	2.18	1.45	0.18	0.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	43.48	16.56	0.00	0.41	0.41	1.24	0.41	0.83	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	17.84	13.20	2.67	0.70	0.70	2.81	0.70	0.56	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	33.31	15.98	2.31	1.35	1.16	4.24	0.58	0.96	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	56.91	24.29	1.39	0.69	1.39	2.78	0.00	2.78	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	17.34	7.55	0.51	0.17	1.20	0.86	1.72	0.34	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	39.45	13.46	1.27	0.46	0.35	2.07	0.58	0.35	0.58
mesenchymal precursor cell - cardiac, donor3	11754-123G8	44.17	15.65	2.79	0.27	0.80	3.32	0.40	0.27	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	56.58	18.64	1.22	0.41	0.54	3.24	1.08	0.68	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	24.61	13.09	1.56	1.14	0.28	2.13	0.00	0.14	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	8.23	7.25	1.98	1.32	0.99	1.32	0.66	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	17.43	9.27	3.18	1.11	0.00	2.77	1.25	0.14	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	19.55	11.87	0.35	0.70	0.70	1.05	0.35	0.35	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	25.32	8.57	3.47	1.02	0.82	3.88	1.02	0.61	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	5.39	7.19	2.52	1.80	1.44	1.80	0.00	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	28.45	11.07	3.21	1.24	0.93	3.52	0.93	0.72	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	20.06	7.52	2.28	0.23	0.23	2.51	0.23	0.46	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	49.09	21.82	3.36	0.42	0.42	6.71	0.00	2.10	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	9.41	5.68	3.59	1.34	0.45	0.75	0.60	0.30	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	20.66	12.60	3.94	1.14	0.26	2.54	0.18	0.44	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	5.52	2.95	1.84	1.84	0.37	2.58	0.37	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	11.45	7.15	2.00	1.14	0.29	1.14	0.29	0.29	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	70.73	32.00	8.42	2.11	0.42	2.95	0.42	1.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	23.29	13.70	2.28	0.46	3.20	5.02	0.46	0.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	24.56	14.58	1.02	0.26	1.02	2.30	0.00	0.51	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	24.34	18.58	2.09	1.31	1.83	3.14	0.79	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	21.87	14.48	1.23	0.92	2.16	2.77	0.00	1.23	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	29.42	17.89	2.59	0.71	0.94	2.59	1.18	1.41	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	25.05	20.65	1.35	0.34	1.02	3.38	0.68	1.02	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	21.61	19.65	2.36	0.39	1.57	1.57	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	30.12	19.93	1.85	1.85	0.46	2.32	0.93	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	32.88	19.90	3.46	0.58	2.31	4.61	0.58	0.58	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	24.99	16.96	1.34	1.12	0.89	2.68	0.22	0.67	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	32.45	20.67	1.92	1.68	0.72	1.68	0.24	0.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	33.00	14.67	2.20	0.73	0.73	4.40	0.00	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	24.17	19.47	1.01	1.01	1.01	3.69	0.00	0.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	21.29	15.15	0.82	0.41	1.64	4.09	0.41	1.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	23.63	15.03	3.01	1.72	0.43	4.73	0.43	0.86	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	32.81	24.61	5.47	0.00	0.00	5.47	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	15.49	5.16	0.00	0.00	5.16	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	21.76	17.21	0.65	0.97	0.65	3.57	0.00	1.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	16.00	21.82	2.91	1.45	2.91	5.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	22.39	19.19	1.07	0.53	0.00	2.67	0.00	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	24.53	14.72	0.82	0.82	2.45	0.82	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	20.99	18.66	1.17	0.00	1.55	2.33	0.00	0.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	16.79	16.79	0.00	0.00	0.00	2.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	21.86	10.93	0.00	0.99	0.99	1.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	9.53	0.00	0.00	4.77	0.00	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	19.57	14.23	0.59	0.59	0.59	3.56	0.00	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	21.93	15.84	0.00	2.44	0.00	3.66	1.22	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	28.50	13.93	0.63	0.00	2.53	4.43	0.63	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	31.73	22.76	1.03	2.41	1.38	2.07	1.03	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	30.09	19.34	0.00	0.00	2.15	4.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	39.92	15.97	3.99	0.00	0.00	3.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	30.99	24.11	3.44	0.00	6.89	0.00	3.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	35.86	15.48	0.81	0.41	2.04	0.81	0.81	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	34.96	18.27	2.38	1.59	6.36	2.38	1.59	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	38.91	17.69	1.18	0.59	3.54	0.59	2.36	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	33.98	15.27	1.87	0.31	3.12	1.56	5.61	0.00	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	29.41	12.03	2.67	0.00	4.01	6.68	4.01	2.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	121.82	27.20	1.18	0.00	5.91	2.37	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	179.76	15.41	0.00	0.00	12.84	5.14	5.14	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	134.93	26.16	2.07	0.00	4.13	4.82	0.00	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	810.00	47.50	2.97	0.00	4.95	3.96	0.99	1.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	643.75	38.13	7.85	1.12	8.97	1.12	2.24	0.00	3.36
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	713.66	34.98	5.09	0.64	12.72	1.27	4.45	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	1140.04	47.15	4.84	0.81	5.64	3.63	3.63	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	1216.77	63.24	10.90	0.00	13.08	4.36	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	1012.38	43.08	6.34	2.53	3.80	0.00	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	931.57	36.41	5.46	1.21	4.86	4.86	1.82	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	1152.34	54.23	4.52	4.52	4.52	4.52	13.56	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	927.46	45.30	5.77	0.82	14.83	4.94	3.29	1.65	2.47
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	219.26	32.74	1.98	0.79	11.11	2.98	1.59	0.99	1.19
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	153.16	30.50	2.60	0.32	7.46	4.22	0.97	0.32	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	148.72	25.47	3.06	0.00	9.17	3.06	2.04	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	10.06	7.74	1.55	0.00	1.55	0.77	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	2.13	5.43	5.20	3.31	1.42	0.47	0.71	0.00	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	54.21	14.36	5.79	4.87	0.93	0.93	0.23	0.70	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	0.82	0.72	0.62	0.21	0.21	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-25	10850-111F4	32.00	10.21	7.72	2.04	0.23	0.91	0.68	0.00	0.23
mesothelioma cell line:Mero-41	10851-111F5	37.40	14.42	2.44	0.98	1.22	1.22	0.73	0.73	0.00
mesothelioma cell line:Mero-48a	10852-111F6	12.18	9.74	3.10	1.55	0.66	2.44	0.00	0.22	0.00
mesothelioma cell line:Mero-82	10853-111F7	12.09	4.73	1.84	1.05	0.53	0.79	0.53	0.53	0.00
mesothelioma cell line:Mero-83	10854-111F8	0.17	0.51	0.68	0.34	0.17	0.17	0.68	0.00	0.17
mesothelioma cell line:Mero-84	10855-111F9	56.37	10.62	1.77	0.25	1.01	0.51	0.25	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	39.34	20.50	6.42	1.66	1.66	1.66	0.83	0.62	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	8.61	6.96	3.15	2.82	0.66	2.82	0.17	0.50	0.00
mesothelioma cell line:NCI-H226	10846-111E9	0.00	0.54	0.36	0.00	0.36	0.00	0.00	0.00	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	16.23	9.22	2.05	0.68	0.17	1.37	0.51	1.02	0.00
mesothelioma cell line:NCI-H28	10845-111E8	9.42	8.40	6.87	2.80	0.25	0.00	0.51	0.25	0.00
mesothelioma cell line:No36	10857-111G2	3.91	3.91	3.26	2.61	0.33	0.00	0.33	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	5.69	2.17	1.90	0.27	0.00	0.00	0.27	0.27	0.00
migratory langerhans cells, donor1	11901-125F2	0.77	1.34	1.15	0.96	0.00	0.19	0.00	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	0.61	1.47	0.24	0.61	0.12	0.00	0.00	0.12	0.00
migratory langerhans cells, donor3	11903-125F4	2.15	2.69	0.54	0.90	0.00	0.18	0.00	0.18	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	9.47	6.20	2.61	4.24	2.29	0.65	2.94	0.65	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	33.70	11.02	1.91	1.70	3.81	0.42	1.06	0.64	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	7.60	4.15	1.15	0.23	0.92	0.23	0.23	0.23	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	81.64	25.88	8.75	2.66	4.76	1.52	2.66	1.14	0.76
myelodysplastic syndrome cell line:SKM-1	10772-110F7	70.78	38.44	17.56	4.25	3.14	1.48	0.55	2.03	0.37
myeloma cell line:PCM6	10474-106I6	35.58	25.89	6.33	2.57	5.73	1.38	0.99	1.78	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	3.04	3.04	1.52	3.55	0.51	0.51	0.00	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	21.58	21.58	2.55	0.78	2.55	2.16	2.35	1.37	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	2.67	2.45	0.78	0.22	2.67	0.67	0.89	0.11	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	3.75	2.43	0.74	0.15	1.91	0.37	1.40	0.07	0.29
nasal epithelial cells, donor2	12227-129F4	11.04	5.52	2.21	1.10	1.66	1.10	0.55	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	33.82	17.94	31.98	7.36	3.91	2.07	3.45	0.92	0.46
neuroblastoma cell line:NB-1	10539-107G8	44.15	21.89	12.72	3.37	0.56	2.43	0.56	0.94	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	8.86	5.69	12.65	4.64	2.53	0.21	3.59	0.21	0.21
neuroblastoma cell line:NH-12	10555-107I6	30.19	16.03	29.82	8.94	2.42	2.42	5.59	1.68	0.93
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	8.78	7.12	11.15	5.69	0.47	0.47	2.61	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	28.35	9.19	10.14	7.76	3.17	0.95	3.48	0.63	0.79
neuroectodermal tumor cell line:TASK1	10774-110F9	35.42	13.08	6.84	3.62	3.22	0.60	0.81	0.40	0.60
neuroepithelioma cell line:SK-N-MC	10728-110A8	6.36	5.72	4.45	6.36	0.64	0.00	1.27	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	19.96	7.98	2.66	1.33	2.93	1.60	1.60	0.00	0.80
neutrophil PMN, donor1	12133-128D9	0.00	14.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	13.28	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	132.08	66.63	11.33	4.23	1.52	1.35	1.01	5.58	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	132.08	68.84	53.63	20.81	7.20	5.60	3.20	4.80	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	17.63	11.54	8.98	6.73	5.13	2.56	1.92	0.64	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	40.47	16.55	4.20	0.53	0.79	1.84	0.79	1.05	0.00
nucleus accumbens, adult, pool1	10037-101F1	34.59	7.59	4.03	7.78	0.94	1.31	1.31	0.47	0.28
occipital cortex - adult, donor10196	10172-103C1	16.48	2.06	2.06	2.06	2.06	2.06	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	19.86	11.54	4.03	9.12	0.27	2.68	0.54	0.00	0.27
occipital cortex, newborn, donor10223	10355-105E4	9.83	4.00	1.82	2.18	2.18	0.00	1.82	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	12.07	7.61	1.31	2.62	1.31	1.05	0.26	1.05	0.00
occipital lobe, fetal, donor1	10073-102A1	6.44	1.29	4.72	8.15	9.44	0.86	0.86	0.00	0.00
occipital pole, adult, pool1	10036-101E9	19.55	7.73	2.52	4.81	1.18	0.79	0.47	0.39	0.32
olfactory region, adult	10195-103E6	15.28	7.26	3.82	8.60	0.57	2.29	1.53	0.38	0.38
optic nerve, donor1	10277-104E7	8.00	6.00	2.00	14.01	10.01	4.00	4.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	9.34	5.81	4.67	1.94	0.80	1.14	0.46	0.11	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	0.00	0.00	0.69	0.82	0.41	0.14	0.27	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	0.00	0.00	0.17	0.00	0.00	0.17	0.00	0.00	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	0.69	1.04	1.50	0.58	0.35	0.35	0.35	0.12	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	26.46	14.70	1.47	1.18	1.76	2.06	0.59	0.88	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	23.36	17.75	11.21	1.87	0.00	1.87	0.93	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	7.21	2.54	4.45	0.42	1.06	0.64	0.21	0.00	0.21
ovary, adult, pool1	10020-101D2	15.55	8.30	3.67	2.18	3.41	4.02	0.87	0.35	0.61
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	12.10	6.42	2.38	1.47	2.57	0.92	0.73	0.18	0.18
pancreas, adult, donor1	10049-101G4	35.74	20.69	5.64	2.82	3.76	0.94	3.76	0.94	3.76
pancreatic carcinoma cell line:NOR-P1	10698-109G5	5.03	5.59	12.86	4.47	1.96	0.00	1.40	0.56	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	8.86	4.60	3.24	0.68	1.53	0.51	0.17	0.00	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	24.84	11.59	4.80	1.66	0.50	0.83	0.33	0.50	0.00
paracentral gyrus, adult, pool1	10035-101E8	22.42	7.23	4.03	6.32	1.46	1.28	0.82	0.73	0.27
parietal cortex, adult, donor10258	10373-105G4	9.54	3.67	0.73	2.94	0.73	1.47	3.67	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	13.17	9.40	2.82	7.52	1.88	1.88	1.88	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	16.25	8.27	3.99	8.84	0.00	1.71	1.14	0.29	0.86
parietal lobe, adult, pool1	10034-101E7	18.77	9.96	3.17	7.93	1.06	2.29	1.15	0.88	0.18
parietal lobe, fetal, donor1	10072-101I9	9.70	8.73	3.88	11.64	13.58	3.88	6.79	0.97	0.97
parietal lobe, newborn, donor10223	10356-105E5	13.83	4.11	2.24	1.12	2.24	1.12	0.75	0.37	0.00
parotid gland, adult	10199-103F1	3.70	4.32	1.23	0.62	0.62	0.62	0.00	0.62	1.23
penis, adult	10200-103F2	29.54	21.48	2.15	3.22	5.37	3.76	2.15	1.07	1.61
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	12.46	7.81	5.21	2.79	2.42	1.12	2.42	0.00	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	0.00	0.15	0.44	0.73	0.58	0.00	0.87	0.00	0.44
pineal gland - adult, donor10196	10179-103C8	6.45	3.23	0.65	1.94	0.00	0.00	0.00	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	3.55	6.51	5.92	5.33	0.59	1.78	0.00	1.18	0.00
pineal gland, adult, donor10258	10377-105G8	9.41	5.02	1.88	5.64	2.51	0.63	3.76	1.88	0.00
pituitary gland - adult, donor10196	10180-103C9	20.24	8.09	19.22	17.20	1.01	2.02	4.05	1.01	1.01
pituitary gland, adult, donor10252	10162-103A9	26.06	12.51	23.45	26.06	1.04	1.04	1.04	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	14.47	14.47	10.21	16.17	9.36	0.85	9.36	2.55	1.70
placenta, adult, pool1	10021-101D3	14.08	11.50	7.31	5.59	2.47	1.51	0.75	0.97	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	20.39	13.11	6.49	5.16	0.40	0.40	0.13	1.32	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	15.88	9.18	1.09	0.78	1.71	2.02	0.16	0.47	0.00
pons, adult, pool1	10033-101E6	13.77	7.49	3.18	7.83	0.43	1.89	0.60	1.03	0.17
postcentral gyrus, adult, pool1	10032-101E5	22.06	6.97	2.44	6.19	2.09	1.83	2.35	0.26	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	6.27	6.27	0.00	0.00	0.00	2.09	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	22.03	11.02	5.51	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	0.00	0.00	0.00	11.74	11.74	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	6.99	7.87	4.81	5.97	0.73	0.58	0.00	0.44	0.15
prostate cancer cell line:PC-3	10439-106E7	9.26	6.53	3.09	3.09	1.45	2.90	0.73	0.36	0.73
prostate, adult, pool1	10022-101D4	24.12	15.60	3.45	2.18	1.54	2.36	1.18	1.00	0.27
putamen, adult, donor10196	10176-103C5	26.44	9.91	3.30	7.55	0.71	0.94	3.30	0.94	0.24
putamen, adult, donor10252	10152-102I8	25.49	11.76	1.96	7.84	9.80	5.88	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	31.69	16.39	15.30	0.00	0.00	1.09	1.09	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	16.91	11.11	4.11	4.59	2.42	0.24	2.42	0.72	0.72
putamen, newborn, donor10223	10365-105F5	13.49	6.75	7.50	0.75	0.00	0.00	0.75	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	29.97	6.98	5.24	1.16	2.33	0.87	0.58	0.00	0.29
rectum, fetal, donor1	10067-101I4	27.82	15.30	12.52	2.78	6.95	2.78	2.78	2.78	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	33.50	22.68	6.36	2.97	0.85	1.06	0.00	1.70	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	14.08	20.71	11.18	10.36	4.56	2.07	0.41	0.83	0.41
retina, adult, pool1	10030-101E3	34.29	17.69	7.75	7.55	2.98	3.88	1.69	0.80	0.60
retinoblastoma cell line:Y79	10475-106I7	1.30	2.34	25.98	14.29	16.89	0.52	3.12	0.00	1.30
rhabdomyosarcoma cell line:KYM-1	10787-110H4	21.39	13.40	8.98	7.25	0.61	0.12	0.49	0.74	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	43.59	23.90	29.81	13.50	0.84	1.69	1.12	1.41	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	14.40	14.40	2.27	1.52	0.76	5.30	1.52	0.00	0.76
salivary acinar cells, donor1	11771-123I7	29.30	18.94	0.81	0.00	0.81	1.62	0.32	0.16	0.16
salivary acinar cells, donor2	11772-123I8	22.58	16.94	1.10	0.69	1.93	3.17	1.93	1.24	0.55
salivary acinar cells, donor3	11773-123I9	10.59	9.27	1.32	0.66	1.99	3.97	1.99	0.66	0.66
salivary gland, adult, pool1	10093-102C3	11.44	5.15	0.57	1.72	1.72	0.57	0.57	1.14	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	14.33	12.31	2.61	1.26	0.08	0.42	0.00	0.17	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	14.58	14.22	4.11	1.06	0.12	0.71	0.12	0.47	0.00
seminal vesicle, adult	10201-103F3	14.28	15.34	2.12	2.12	4.23	0.00	1.06	1.06	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	1.94	0.97	1.94	0.49	0.97	1.21	0.24	0.00	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	0.00	0.00	0.00	0.25	0.25	0.00	0.00	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	8.46	5.10	11.42	4.57	1.34	0.27	2.15	0.27	0.67
signet ring carcinoma cell line:Kato III	10436-106E4	184.69	28.30	8.07	0.44	1.44	3.21	0.11	0.55	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	1.55	2.58	1.81	1.55	0.26	0.39	0.26	0.13	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	46.11	27.66	0.71	4.26	3.55	2.84	2.13	1.42	0.71
skeletal muscle, adult, pool1	10023-101D5	47.02	29.02	1.44	1.32	3.72	2.40	0.36	3.60	0.00
skeletal muscle, fetal, donor1	10066-101I3	20.10	10.05	7.04	6.03	11.06	4.02	1.01	0.00	0.00
skin, adult, donor1	10074-102A2	6.79	33.93	0.00	0.00	6.79	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	33.46	15.78	6.31	0.63	1.89	5.68	1.26	1.26	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	47.69	18.68	17.34	9.67	4.67	2.67	4.34	0.67	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	67.45	22.06	23.64	5.99	5.67	6.93	4.73	1.26	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	4.82	3.85	16.00	16.77	4.05	0.39	1.16	0.00	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	49.12	24.72	24.23	5.77	1.32	3.46	0.66	0.99	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	17.21	8.36	28.15	13.67	1.93	0.16	1.77	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	53.39	16.13	21.79	11.99	3.70	5.88	4.14	0.65	0.87
small intestine, adult, pool1	10024-101D6	193.50	44.07	37.74	1.55	2.03	11.94	0.60	1.07	0.24
small intestine, fetal, donor1	10064-101I1	23.10	15.23	25.06	4.42	4.18	3.44	3.69	0.49	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	12.82	6.67	12.82	3.08	5.64	1.54	2.05	0.00	0.51
smooth muscle, adult, pool1	10048-101G3	20.42	15.25	7.75	1.81	4.91	3.62	5.43	1.03	1.81
somatostatinoma cell line:QGP-1	10781-110G7	18.76	11.26	13.94	4.29	3.75	1.61	3.75	0.80	0.54
spinal cord - adult, donor10196	10181-103D1	12.85	9.86	7.57	20.19	0.46	2.52	1.61	0.46	0.00
spinal cord, adult, donor10252	10159-103A6	13.41	7.89	7.10	15.38	0.39	4.34	0.00	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	24.21	20.06	6.92	2.77	0.69	2.77	0.69	1.38	0.00
spinal cord, fetal, donor1	10056-101H2	15.86	5.49	6.71	10.37	3.66	1.22	1.22	1.22	1.83
spinal cord, newborn, donor10223	10359-105E8	25.26	10.10	5.51	4.13	0.92	1.84	1.38	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	22.85	12.84	0.90	0.75	1.19	1.19	0.90	0.60	0.30
spleen, adult, pool1	10025-101D7	18.94	14.87	3.96	1.32	0.88	1.10	0.44	0.33	0.22
spleen, fetal, pool1	10044-101F8	16.37	9.38	4.21	1.59	0.79	1.03	1.03	0.08	0.40
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	46.37	25.46	7.35	3.52	0.10	0.21	0.41	1.66	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	0.19	0.19	0.38	0.57	0.19	0.00	0.00	0.00	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	44.38	6.29	6.29	6.99	0.70	2.45	0.00	0.70	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	0.00	0.39	0.39	0.00	0.00	0.00	0.78	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	8.33	5.63	1.01	0.56	1.80	0.79	0.68	0.23	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	0.42	0.42	1.69	1.27	0.00	0.00	0.00	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	5.50	5.08	2.12	0.00	0.00	0.42	0.00	1.69	0.00
stomach, fetal, donor1	10062-101H8	29.90	14.95	3.20	6.41	8.54	1.07	3.20	0.00	0.00
submaxillary gland, adult	10202-103F4	3.42	1.71	1.14	0.00	2.85	0.00	0.57	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	108.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	18.28	14.75	9.14	10.59	0.62	4.36	2.08	0.83	0.83
substantia nigra, adult, donor10258	10371-105G2	26.38	10.35	2.59	4.14	1.55	0.52	3.62	2.59	0.52
substantia nigra, newborn, donor10223	10358-105E7	10.60	5.65	2.12	7.77	0.00	0.71	0.71	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	20.18	15.82	21.55	20.40	4.59	0.23	1.38	0.23	0.00
temporal lobe, adult, pool1	10031-101E4	22.29	8.05	2.71	5.76	3.05	1.02	1.44	0.68	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	3.56	2.14	4.99	9.97	2.85	0.71	0.71	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	6.59	1.32	3.96	3.52	3.08	1.76	0.88	0.88	0.00
tenocyte, donor1	11763-123H8	21.64	18.85	2.44	0.70	1.75	5.24	0.70	1.40	0.35
tenocyte, donor2	11765-123I1	25.94	25.18	1.53	1.14	7.25	4.96	3.43	1.53	0.76
tenocyte, donor3	11768-123I4	23.72	22.98	0.00	0.37	0.74	5.56	1.85	1.11	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	23.79	13.77	39.43	9.18	0.68	1.53	1.19	0.85	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	42.54	11.10	18.04	5.09	3.24	0.15	1.08	1.23	1.08
teratocarcinoma cell line:PA-1	10807-111A6	7.75	8.83	29.60	8.83	1.55	0.46	0.93	0.77	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	3.17	3.17	19.04	2.79	1.40	1.52	0.38	0.25	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	7.94	11.35	23.82	5.29	0.38	0.38	0.76	0.38	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	12.54	8.07	35.77	3.38	0.87	1.42	0.55	0.33	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	13.03	9.12	48.20	7.82	1.30	1.95	1.63	0.33	0.00
testis, adult, pool1	10026-101D8	23.73	13.96	9.99	10.63	4.08	2.25	1.61	0.86	0.75
testis, adult, pool2	10096-102C6	16.69	9.02	11.28	13.53	4.96	1.80	1.35	0.00	0.90
thalamus - adult, donor10196	10168-103B6	12.14	17.66	7.73	8.83	0.00	1.10	1.10	1.10	1.10
thalamus, adult, donor10252	10154-103A1	23.75	13.91	7.03	11.88	0.78	4.06	1.09	0.63	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	20.02	12.32	9.24	3.08	4.62	3.08	7.70	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	9.55	6.75	2.47	5.93	2.14	1.15	1.48	1.32	0.00
thalamus, newborn, donor10223	10366-105F6	14.96	4.03	2.88	2.88	1.73	1.15	0.58	0.00	0.00
throat, adult	10209-103G2	17.98	14.48	1.00	2.75	1.25	1.00	0.25	0.50	0.50
throat, fetal, donor1	10061-101H7	22.55	18.59	8.53	7.01	6.09	4.88	5.48	0.00	1.52
thymic carcinoma cell line:Ty-82	10803-111A2	0.20	0.79	1.39	0.99	0.20	0.20	0.00	0.00	0.00
thymus, adult, pool1	10027-101D9	23.16	14.32	7.26	5.47	2.58	0.30	1.89	1.29	0.89
thymus, fetal, pool1	10043-101F7	19.33	13.09	5.82	4.88	0.94	0.52	0.62	0.73	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	14.89	16.89	7.18	2.13	0.40	1.20	0.40	0.80	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	11.31	4.33	0.42	0.14	1.40	0.84	1.12	0.56	0.28
thyroid, adult, pool1	10028-101E1	72.97	18.20	6.44	7.65	3.08	1.87	1.40	0.47	0.56
thyroid, fetal, donor1	10060-101H6	15.56	7.38	4.22	6.33	8.96	2.90	6.06	0.79	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	3.08	18.48	0.00	0.00	3.08	0.00	0.00	0.00	3.08
tongue, adult	10203-103F5	24.19	16.28	3.02	1.40	2.33	0.70	0.23	0.93	0.00
tongue, fetal, donor1	10059-101H5	35.07	27.59	5.52	5.91	3.15	3.15	1.18	1.97	0.39
tonsil, adult, pool1	10047-101G2	13.12	12.42	3.31	1.60	1.70	0.70	0.80	0.80	0.90
trachea, adult, pool1	10029-101E2	17.26	8.67	1.88	0.98	0.98	1.55	0.25	0.33	0.25
trachea, fetal, donor1	10058-101H4	13.08	10.00	5.00	0.77	13.08	2.69	6.16	1.15	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	19.13	8.86	0.35	0.00	1.06	0.71	0.00	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	46.10	17.73	4.76	0.71	1.01	1.32	0.00	0.71	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	17.24	11.28	4.23	4.39	0.94	0.94	0.47	1.10	0.00
tridermal teratoma cell line:HGRT	10694-109G1	3.81	5.71	0.00	1.90	0.00	0.00	0.00	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	17.44	9.90	1.69	0.51	0.76	0.93	1.27	0.25	0.08
umbilical cord, fetal, donor1	10057-101H3	39.64	22.95	4.17	6.26	2.09	2.09	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	16.72	8.70	6.31	1.71	1.19	4.10	1.19	0.51	1.02
uterus, fetal, donor1	10055-101H1	9.21	8.70	7.17	5.12	22.01	2.56	2.56	2.56	0.51
vagina, adult	10204-103F6	9.05	6.46	3.23	0.65	3.88	1.94	0.00	0.00	1.94
vein, adult	10191-103E2	47.35	17.54	3.07	1.53	3.73	1.53	1.10	1.10	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	14.15	10.95	4.01	2.67	0.00	0.00	1.07	0.27	0.00